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Abstract 
Despite recent improvements in the clinical outcomes of vital pulp treatment, existing 
approaches remain non-specific and unpredictable. Developing biologically-based therapies 
that promote pulp regeneration is critical. Epigenetic modifications of DNA and histones 
control cellular processes, including proliferation, mineralisation and stem cell fate, and 
therefore offer exciting therapeutic opportunities. Chromatin acetylation can be altered 
pharmacologically using histone-deacetylase-inhibitors (HDACis), which relax its structure 
and modulate transcription. This project investigated regenerative-associated HDACi effects 
in vitro on a cell-line and primary dental-pulp-cells (DPCs), using proliferation, viability, 
mineralisation, cell-migration, enzyme activity, high-throughput gene/protein expression 
and pathway analyses. HDACis increased DPC differentiation and mineralisation-associated 
gene/protein expression at concentrations, which did not reduce viability. Primary DPC 
mineralisation was promoted without altering cell viability/apoptosis, indicating a resistance 
to HDACi-mediated toxicity compared with cell-lines. HDACi-induced DPC reparative 
processes were mediated by matrix metalloproteinase (MMP) expression and activity. MMP-
13 inhibition further increased mineralisation-associated events, but decreased cell-
migration indicating a novel role for MMP-13 in pulpal repair. HDACi solutions released a 
range of previously characterised and unreported bioactive dentine matrix components, 
which may further supplement regenerative capability in vivo. Results demonstrate that 
HDACi directly stimulate DPC repair-associated events, highlighting their potential for 
augmenting dental materials or pulp-engineering scaffolds for regenerative endodontics. 
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CHAPTER 1 
 
GENERAL INTRODUCTION 
 2 
1.1 Dental pulp infection, injury and repair  
The preservation of healthy dental pulp tissue and subsequent prevention of apical disease, 
form the biological basis of operative dentistry. In a healthy tooth, the pulp is naturally 
protected by a mineralised outer shell of enamel and dentine, while also possessing a range 
of cellular defence strategies designed to protect against injury. The pulp can be challenged 
by stimuli including caries, trauma and dental restorative dental procedures, all of which 
provoke inflammatory responses in the pulp, the nature and extent of which reflects the 
severity of the challenge (Mjör & Tronstad, 1972). Microbial infection in caries lesions or 
‘leakage’ around dental restorations provides the principal pulpal challenge, as bacterial 
products diffusing through the dentinal tubules induce inflammation even when the caries 
process or the restoration has not yet reached the pulp (Warfvinge & Bergenholtz, 1986).  A 
range of pulp cells react immunologically to the microbes including initial pathogen 
recognition by odontoblasts and later fibroblasts, stem cells and immune cells; thereafter, a 
complex series of antibacterial, immune and inflammatory responses are activated (Farges 
et al., 2009 & 2015; Soden et al., 2009). As the carious process advances towards the pulp, 
the inflammatory process intensifies and the nature of the bacterial microflora change from 
aerobic to predominately anaerobic in deep carious lesions (Nadkarni et al., 2004; Chhour et 
al., 2005).  If the caries progresses untreated, the microbial biofilm will advance and the 
associated bacteria will invade the tissue. This aggressive bacterial challenge invariably leads 
to irreversible pulpitis, pulp necrosis and subsequent apical periodontitis (Reeves & Stanley, 
1966). Over time the bacterial flora in the diseased pulp and the subsequent necrotic root 
canal system change from comprising principally facultative anaerobic bacteria to more 
gram-negative, obligate anaerobic bacteria (Fabricius et al., 1982; Rôças et al., 2015). Pulp 
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necrosis will necessitate remedial dental treatment, such as tooth extraction or root canal 
treatment.  
Pulp tissue, however, has an innate ability to heal if the challenge is removed and the 
tooth is suitably restored (Mjör & Tronstad, 1974). It appears that a controlled level of 
inflammation is critical, at least initially, to drive the repair process (Cooper et al., 2010). If 
possible, biologically-based treatments, such as pulp capping and pulpotomy, aiming to 
maintain an intact pulp are preferable to root canal treatment, which is more costly, 
complex, time-consuming and destructive of sound tooth tissue (Stanley, 1989; Reeh et al., 
1989). Clinically, maintaining pulp vitality is of particular importance if the tooth is immature 
and root formation is incomplete. 
 
1.1.1 Dentine and pulp 
The dental pulp occupies the centre of the tooth (Fig 1.1) and is responsible for forming 
dentine developmentally and throughout the life of the tooth. Odontoblasts are located at 
the periphery of the pulp, forming an interface with the dentine, which results in an 
anatomically and functionally linked tissue, traditionally referred to as the dentine-pulp or 
pulpo-dentine complex (Pashley, 1996). The odontoblast is a secretory cell responsible for 
the formation or primary dentine during tooth development and later for both the slower 
production of secondary dentine throughout the lifetime of the tooth and for tertiary 
dentine production when challenged (Simon et al., 2009). Additionally, odontoblasts are 
involved in sensory stimulus transmission from the dentine and play an immunocompetent 
role in cellular defence (Couve et al., 2013). A thin enamel layer generally protects the 
underlying pulp-dentine complex, which if its integrity is compromised by microbes, wear or 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Schematic of the processes of tertiary dentine formation. Reactionary and reparative 
dentinogenesis processes differ in the source of the secreting cell. Reactionary dentine is formed by the 
existing primary odontoblast with a mild stimulus (early stage carious disease) stimulating upregulation of 
existing odontoblast activity. During the reactionary dentinogenesis process the odontoblasts recognise the 
bacterial products and released dentine matrix components (DMCs) diffusing through the dentine tubules, 
which increases cellular activity. Reparative dentine formation involves a more complex sequence of events in 
which a severe stimulus (increased carious involvement of dentine) causes death of the primary odontoblasts, 
which are subsequently replaced following differentiation of progenitor or stem cells into odontoblast-like cells 
under the regulation of bioactive molecules (including DMCs). As the nature of the cellular response is likely to 
be dependent upon the pulp environment, the mineralised tissue deposited at the pupal wound site will likely 
display a spectrum of dysplasia. A  Enamel, B Dentine, C Pulp. 
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operative procedures, places the pulp at risk of harm. The pulp tissue responds to these 
challenges by localised inflammation and the production of tertiary dentine, which forms 
beneath the area of challenge (Lesot et al., 1994; Smith, 2002). There are two types of 
tertiary dentine formed (Fig 1.1) depending on the severity of the irritating stimulus; mild 
irritation induces an up-regulation of existing odontoblast activity to form reactionary 
dentine, while stronger stimuli result in odontoblast death and the recruitment of dental 
pulp stem/progenitor cells, which differentiate into odontoblast-like cells to form reparative 
dentine (Lesot et al., 1994). This cyto-differentiation and reparative dentine formation is 
regulated by bioactive molecules, including bone morphogenic proteins and growth factors 
(GF), which are ‘fossilized’ in the dentine matrix (Cassidy et al., 1997; Smith, 2003; Grando 
Mattuella et al., 2007) prior to being released by caries, trauma or dental materials (Graham 
et al., 2006; Tomson et al., 2007). 
Clinically, the reparative dentine forms a mineralised bridge, which helps protect the 
pulp tissue from further insult (Glass & Zander, 1949; Nyborg, 1955). Reparative dentine 
formation evidently involves a complex series of biological events, which are not fully 
elucidated, however, bioactive molecules released from the dentine or pulp matrix and from 
altered pulp cell transcription following injury to the pulp-dentine complex are central to the 
process (Rutherford et al., 1993; Nakashima, 1994; Cassidy et al., 1997; Smith & Lesot 2001; 
Iohara et al., 2004). From a histological viewpoint, pulp exposure healing should be 
described as the formation of a continuous hard tissue barrier over the exposure and a 
residual pulp, free of inflammation (Schröder, 1973). However, treatment outcomes for pulp 
capping can only be evaluated clinically and radiographically (Woehrlen, 1977; Fuks et al., 
1982).  
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1.1.2 Dental pulp and progenitor cells  
During reparative dentinogenesis, the recruitment of a progenitor cell population to the 
injury site, prior to their expansion and differentiation into odontoblast-like cells, is central 
to the ability of the dental pulp to repair (Smith et al., 2016). However, the location and 
nature of the progenitor cells are the subject of debate, and they have been attributed to 
stem cell (SC) populations within the pulp (Smith & Lesot, 2001), SCs migrating from outside 
the tooth (Feng et al., 2011; Frozoni et al., 2012) and also undifferentiated mesenchymal 
cells from cell-rich and central pulp perivascular regions, namely pericytes (Fitzgerald et al., 
1990; Machado et al., 2015). At present, there is a lack of consensus regarding the 
progenitor population responsible for reparative dentine formation, although surface 
marker analysis generally confirms a mesenchymal origin (Simon & Smith, 2014).  Within the 
pulp core, there are two characterised post-natal SC populations, dental pulp SCs (DPSCs) 
and SCs from human exfoliated deciduous teeth (SHEDs), which reportedly account for 1-5% 
of total permanent and 2-9% deciduous pulp cell populations, respectively (Gronthos et al., 
2000; Miura et al., 2003; Coppe et al., 2009).  DPSCs, like other SC populations (Crisan et al., 
2008), reportedly reside in perivascular areas, potentially to enable mobilisation to the 
wound site (Shi & Gronthos, 2003; Casagrande et al., 2011). Critically, the influence of 
infection and pulp inflammation will alter the cellular response and quality of the mineral 
produced (Ricucci et al., 2014) and as a result, the interaction of inflammation, materials and 
SCs post-injury needs to be fully understood if the development of innovative regenerative 
solutions are to be realised (Cooper et al., 2010).  
 
 6 
1.1.3 Regenerative endodontics and treatment of the exposed pulp 
There is a history of pulp preservation within restorative dentistry, which can be traced back 
to the 18th century (Glass & Zander, 1949), when gold was inserted over an exposed pulp to 
promote healing.  During the course of the last century, the popularity of these pulpal 
regenerative techniques has fluctuated, with Rebel seminally stating that ‘the exposed pulp 
is a doomed organ’ (Rebel, 1922). Unfortunately, this message has endured despite decades 
of research on the subject indicating results to the contrary (Nyborg, 1955 & 1958; Haskell et 
al., 1978; Baume & Holz, 1981; Schröder et al., 1985; Farsi et al., 2006; Bogen et al., 2008; 
Hilton et al., 2013). The reluctance of clinicians to accept vital pulp treatment procedures 
may be due to often unpredictable results when compared with more conventional forms of 
treatment, such as root canal therapy (Strindberg, 1956; Haskel et al., 1978; Barthel et al., 
2000), which can be attributed at least in part, to an incomplete understanding of pulp 
biology and the interaction with dental restorative materials. Recently, a better 
understanding of pulp defence and repair (Smith, 2002), the advent of new improved dental 
materials (Moghaddame-Jafari et al., 2005; Nair et al., 2008) and the promotion of 
regenerative endodontic therapies (Smith, 2002; Murray et al., 2007; Nair et al., 2008) has 
stimulated a new wave of research and treatment protocols in this area. As a result, vital 
pulp treatment procedures, within the last ten years, have demonstrated a predictable 
outcome approaching or even exceeding that of conventional root canal treatment 
(Qudeimat et al., 2007; Bogen et al., 2008; Hilton et al., 2013). 
In essence, pulp capping procedures can be viewed as being akin to natural bone 
healing  processes with restorative treatments facilitating pulp-dentine GF release (Smith et 
al., 2016), which stimulates the migration and differentiation of progenitor cell populations 
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within the extracellular pulp matrix to enable a regenerative response at the injury site 
(Schneider et al., 2014; Smith et al., 2016). Perhaps controversially, these treatments have 
been excluded from classification as regenerative endodontic techniques (Murray et al., 
2007), which appears at odds with the recent American Association of Endodontics (AAE) 
definition of regenerative endodontics, ‘biologically-based procedures designed to replace 
damaged structures, including dentin and root structures, as well as cells of the pulp dentin 
complex’ (AAE, 2012). Clearly this definition places pulp capping firmly in this category.   
 
1.1.4 Challenges associated with current pulp preservation treatments  
Traditional pulp capping materials, such as calcium hydroxide [Ca(OH)2] and more recent 
resin-based composites (RBCs), have limited success in part due to their inability to prevent 
microleakage at the tooth-material interface (Bergenholtz et al., 1982; Hilton et al., 2002) as 
well as the toxicity of their constituents (Mantellini et al., 2003; Pananjpe et al., 2008). The 
development of materials, such as mineral trioxide aggregate (MTA) (Fig. 1.2) and 
Biodentine, have offered improvements over existing materials, demonstrating superior 
histological responses (Nair et al., 2008; Nowicka et al., 2015), as well as improved clinical 
outcomes (Mente et al., 2014). Reportedly, Ca(OH)2, stimulates a reparative response by 
non-specific mechanisms (Sangwan et al., 2013), which appear to involve a modulation of  
pulpal inflammation and the creation of an environment conducive to tissue repair. The non- 
specific nature of the response to these materials creates problems for scientists and 
clinicians in elucidating both the specific response to material application and also, in 
devising targeted repair solutions. Ca(OH)2 exhibits other limitations as the hard tissue 
bridges beneath these 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2 Histological response to pulp capping. i. Macrophotographic view of the mesial half of a human maxillary third molar demonstrating the remnants of a 
restorative material (A) and MTA™ capping material (B) at 1 month.  Note the distinct hard tissue bridge (arrow) (original magnification X8). ii. Photomicrograph of a 
histological section of the specimen in i. of a MTA™ pulp cap at 1 month. Note that the mineralised barrier (arrow) stretches across the entire width of the exposed pulp (C) 
(original magnification ×16). iii. Higher magnification photomicrograph from i & ii. Cuboidal cells (arrows) line the hard tissue barrier (D), note the absence of inflammatory 
cells in the pulp (E) (original magnification ×85). iv. Photomicrograph of a selected serial section of hard-setting cement (Dycal™) at 1 month.  Engorged blood vessels are 
prominent and inflammatory cells are present. Note the presence of Dycal™ particles (arrows) in the pulp (F) (original magnification ×16). Images adapted from Nair et al., 
2008. 
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dressings are generally incomplete and contain ‘tunnel’ defects (Fig. 1.2) that are often 
associated with inflammation or necrosis (Cox et al., 1996). Although MTA induces more 
complete hard tissue barriers (Nair et al., 2008), limitations with regard to handling concerns 
and post-operative tooth discolouration have been reported (Felman & Parashos, 2013). 
 
1.1.5 Opportunities for new therapies 
Currently available dental restorative materials do not fulfil the ‘ideal’ properties of a pulp 
capping material (Scarano et al., 2003), namely to; i) maintain the vitality of the dental pulp, 
ii) promote the formation of a mineralised bridge, iii) possess appropriate mechanical 
properties, iv) form an adhesive bond to dentine (prevent microleakage), and v) be insoluble 
and be easy to handle clinically. The limitations of current pulp capping materials have 
driven the development of targeted bio-inductive alternatives that can both prevent 
microleakage and promote dentine-pulp regenerative events (Ferracane et al., 2010). 
Augmenting existing dental restorative materials with anti-oxidants (Kojima et al., 2008; 
Paranjpe et al., 2008), antibiotics (Imazato et al., 2007; Kamocki et al., 2015), the application 
of growth factors (Smith, 2003; Zhang et al., 2011) and gene therapy approaches (Nakashima 
et al., 2003) have all been proposed as potential approaches to generate biologically-
focussed dental materials. While growth factor and gene therapy solutions hold considerable 
future promise, they are limited by expense, dose-response effects, carrier issues and 
practical applicability (Tzafias, 2004; Smith et al., 2008). The potential use of relatively 
inexpensive readily available epigenetic-modifying agents to influence SC function and 
promote mineralisation has been recently highlighted in other disciplines (Schroeder & 
Westendorf, 2005; Humphrey et al., 2008) and may provide a bio-inductive material 
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solutions in dentistry (Duncan et al., 2011). Currently, however, their pulpal effects have not 
been thoroughly elucidated within restorative dentistry. 
 
1.2 Epigenetics 
Deoxyribonucleic acid (DNA) is condensed within the nucleus of all eukaryotic cells in a 
repeating nucleosome structure, which represents 147 base pairs of DNA tightly bound to a 
group of histone proteins to form chromatin (Luger, 2003; Hake et al., 2004). Each 
nucleosome contains two copies of each of the four core histone proteins (H2A, H2B, H3 and 
H4), while the nucleosomes are bound together by a range of proteins including the linker 
histone H1 (Kornberg & Lorch, 1999). A feature of the histone proteins is the presence of 
positively charged ‘tails’, high in arginine or lysine residues, which are frequently subject to 
post-translational modifications such as acetylation, methylation and phosphorylation 
(Spange et al., 2009; Gordon et al., 2015). Although every human cell contains the same 
genetic information, not all genes are expressed at any given time (Portela & Esteller, 2010) 
with transcription tightly orchestrated by complex molecular mechanisms, which enable 
certain genes to be expressed and others suppressed depending on cellular and tissue 
requirements (Horn & Peterson, 2002).  Molecular signalling alters gene transcription by 
modifying the conformation of the chromatin structure, which dynamically condenses and 
relaxes limiting or permitting transcription factor access to the DNA (Kleff et al., 1995; 
Margueron et al., 2005; Vaissière et al., 2008). This chromatin remodelling can be achieved 
by several mechanisms, including covalent alteration of core histone ‘tails’, modification of 
the DNA itself and disruption of the nucleosome structure (Hake et al., 2004). 
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These epigenetic ‘tags’ (or modifications) of chromatin are generally defined as 
alterations, which do not change the DNA sequence, but affect the chromatin architecture 
and its accessibility resulting in an alteration to gene expression that is heritable through cell 
division (Barros & Offenbacher, 2009; Arnsdorf et al., 2010; Cardoso et al., 2010). This 
epigenetic concept, while currently topical, actually dates back to 1942 when Conrad 
Waddington introduced the term ‘epigenetic landscape’ to describe the molecular 
mechanisms responsible for converting genetic information into a specific phenotype 
(Waddington, 1942). Our scientific understanding of the cellular role of epigenetics has 
evolved into a detailed analysis of the effect of a range of modifications on chromatin 
architecture, the effects on gene (Jaenisch & Bird, 2003) and non-coding ribonucleic acid 
(RNA) expression (Gloss & Dinger, 2016) and subsequent influences on cellular phenotype 
(Bostock et al., 2009). As a result, epigenetic modifications of chromatin structure have been 
the focus of considerable research interest recently due to their roles in disease aetiology 
and their potential ability to be targeted and reversed by therapeutic strategies (Kelly et al., 
2010; Portela & Esteller, 2010; Marks, 2010).   
 
1.2.1 Epigenetic modifications 
The two principal types of epigenetic modifications are; i) DNA methylation (Nagase & 
Ghosh, 2008) and ii) post-translational modification of histone proteins (Vaissière et al., 
2008) (Fig. 1.3).  Other less characterised epigenetic modifications have also been described 
including nucleosome positioning (Portela & Esteller, 2010) and chromatin’s organization of 
functional regulatory domains (Lian, 2015). Although it is useful from a didactic perspective 
to categorise epigenetic modifications and study their influence in isolation, it is likely that 
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physiologically a complex interplay will exist between modifications, such as histone 
acetylation and phosphorylation and DNA methylation (Daujat et al., 2005; Milutinovic et al., 
2007; Ou et al., 2007; Vaissière & Herceg, 2010). 
 
1.2.1.1      DNA methylation 
The most studied epigenetic modification is the methylation of CpG paired residues directly 
on DNA (Portela & Estreller, 2010), which results in the covalent attachment of a methyl 
group (-CH3) to the carbon-5’ position of the cytosine ring (Illingworth & Bird, 2009) (Fig. 
1.3). Until recently, it was understood that methylation exclusively occurred in specific 
regions of DNA where CpG dinucleotides were clustered, termed CpG islands. However, 
methylation events have been demonstrated to occur more widely at other sites in 
embryonic SCs (ESCs) (Lister et al., 2009). Notably, CpG islands are not evenly distributed 
throughout the genome, but tend to locate in gene promoter regions (Cooper et al., 1983; 
Larsen et al., 1992), which support the hypothesis that heritable DNA methylation, could 
provide a mechanism for the developmental regulation of gene expression (Riggs, 1975; 
Holliday & Pugh, 1975). Indeed, CpG island-methylation tends to be characterised by a 
transcriptionally repressive state and gene silencing (Weber et al., 2007). Notwithstanding, it 
is an oversimplification to suggest that hypermethylation has a direct correlation with the 
suppression of associated genes as this relationship remains relatively weak (Oakes et al., 
2007). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 Diagram of principal epigenetic modifications. i. Methylation (-CH3) of chromosomal DNA, wrapped 
around the histone protein octamer, generally occurs on cytosine residues at specific regions called CpG 
islands, which generally overlap gene promoter regions. DNA methylation changes are considered stable 
epigenetic modifications and are catalysed by DNA methyltransferase enzymes. The methylation status of DNA 
is considered key to regulating cellular transcription processes. ii. Histone modifications, including acetylation, 
of positively charged acetyl tails alters the conformation of chromatin promoting gene expression and 
pleiotropic cellular effects. In contrast to methylation changes these are considered labile modifications, 
thereby presenting an attractive therapeutic target. The epigenetic modification of these core proteins is 
enzymatically controlled by histone deacetylase (HDAC), histone acetyl transferase (HAT) and histone 
demethylase enzymes. The nucleosome structure can move along the linker DNA strand facilitating changes in 
gene transcriptional activity.  
i. 
ii. 
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Individual DNA methylation patterns are established and maintained by the cellular 
enzymes, DNA methyltransferases (DNMTs), which transfer a -CH3 group to the cytosine 
residue from the universal methyl donor S-adenosyl-L-methionine (Jin & Robertson, 2013). 
There are five members of the DNMT family (DNMT-1, -2 -3a, -3b, -3l), which establish stable 
epigenetic DNA ‘tags’ and from a therapeutic perspective, are potentially reversible (Holliday 
& Pugh, 1975). Following DNA methylation, the exposed -CH3 groups on the cytosine 
nucleotides inhibit transcription directly by precluding the recruitment of DNA binding 
proteins (Kuroda et al., 2009). Subsequently, methyl-CpG-binding domain proteins are 
attracted to the DNA and act in synchrony with histone deacetylase (HDAC) enzymes and 
remodelling complexes to alter chromatin architecture (Portela & Esteller, 2010). DNA 
methylation processes are considered essential for mammalian development (Robertson, 
2005) with an increase in DNA-methylation broadly leading to an inhibition of gene 
expression (Auclair & Weber, 2012), while demethylation promotes transcriptional activity 
(Narlikar et al., 2002). It appears that DNMTs are essential for genomic integrity and 
disruption of their activity has been linked to chromosome instability, neurodegenerative 
diseases and neoplasia (Goelz et al., 1985; Urdinguio et al., 2009). 
Methylation status is altered in cancerous cells and is characterised by severe global 
hypomethylation, although hypermethylation at certain CpG islands has also been reported 
(Goelz et al., 1985). From a therapeutic endodontic perspective, a link between methylation 
status and inflammation is emerging in medicine and dentistry (Bayarsaihan, 2011) and has 
recently been a focus of attention in the dental pulp (Cardoso et al., 2014) and periapical 
area of the tooth (Campos et al., 2016). A beneficial effect of DNMT inhibitors and the 
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promotion of mineralisation processes have recently also been demonstrated in both bone 
(Yan et al., 2014) and dental pulp studies (Zhang et al., 2015). 
 
1.2.1.2      Histone modifications 
Core histones can be modified by methylation, acetylation, phosphorylation, ubiquitination 
and SUMOylation (Zhang & Reinberg, 2001; Kelly et al., 2010). However, in contrast to the 
stability of DNA methylation changes, histone modifications are considered more labile 
epigenetic ‘tags’, being readily reversible (Kelly et al., 2010). Histone tail modification 
induces pleiotropic cellular effects including transcription, DNA repair processes and 
chromosomal condensation, with notably the facilitation or inhibition of transcription being 
dependent on both the histone residue affected and the specific modification type 
(Kouzarides, 2007; Huertas et al., 2009). These covalent modifications are generally 
controlled homeostatically by enzymatic activity, with an imbalance leading to aberrant 
histone alteration, which is evident in disease states (Jones & Baylin, 2007). The enzymatic 
balance and the reversible nature of the histone modifications, however, also provide an 
opportunity for therapeutic intervention (Bolden et al., 2006). As a result, histone 
deacetylation (Grant et al., 2007) and more recently histone methylation inhibitors, have 
been investigated in clinical trials for the treatment of cancer, while preclinical trials using 
deacetylation inhibitors are ongoing for the treatment of inflammatory and 
neurodegenerative disorders (Maes et al., 2015; Momparler & Côté, 2015).  
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1.2.1.2.1     Methylation 
Histone proteins are methylated on arginine and lysine residues only (Zhang & Reinberg, 
2001). In addition, the transcription effects of methylation are also residue-dependent with 
trimethylation of certain histone residues, H3K4 and H3K79, being associated with a 
transcriptionally active chromatin state, while high methylation levels of other residues, 
H3K27 and H4K79, are associated with inactivity (Li et al., 2007). Altered methylation 
patterns have been established in disease states with demethylation of H4K20me3 
associated with cancer (Jones & Baylin, 2007), while increased methylation of H3K9me3 was 
linked to Huntington’s disease (Urdinguio et al., 2009). Different epigenetic modifications 
appear to be interrelated, with high levels of acetylation linked to the high levels of H3K4 
and H3K36 methylation and an open euchromatin state (Li et al., 2007). There is also an 
established interrelationship between histone lysine methylation and DNA methylation 
processes during developmental processes (Rose & Klose, 2014). The enzymes which 
catalyse the modifications, histone methyltransferases and histone demethylases, are 
specific to individual histone subunits and residues (Kouzarides, 2007), but can also 
methylate non-histone proteins (Huang & Berger, 2008). Interestingly, as histones can be 
methylated at several sites simultaneously it appears that it is the combination of marks that 
determine the overall influence on transcription and cell phenotype (Wang et al., 2008).  
 
1.2.1.2.2     Acetylation 
Acetylation of lysine residues in the positively charged histone ‘tail’ is the most clearly 
elucidated histone modification (Philips, 1963) and is associated with an open 
transcriptionally active chromatin state; conversely, deacetylation is associated with gene 
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silencing (Kleff et al., 1995; Taunton et al., 1996). The conformational relaxation of the 
tightly bound chromatin structure creates a remodelled structure in which proteins can 
access DNA to facilitate transcription and gene expression (Grewal & Moazed, 2003; Hake et 
al., 2004). Two groups of balancing enzymes, histone acetyl transferases (HATs) and histone 
deacetylases (HDACs), control the homeostatic balance and alterations in this balance affect 
gene expression (Yang & Seto, 2008). HDACs are also active on a plethora of non-histone 
substrates, including transcription factors and signalling mediators (Glozak et al., 2005; Lee & 
Workman, 2007) and as a result, the term deacetylases may be a better descriptor for their 
cellular function (Balasubramanian et al., 2009).   
 
1.2.1.2.3     Other histone modifications 
Although phosphorylation, ubiquitination and SUMOylation of the histone tails of core 
proteins are less well elucidated than histone methylation and acetylation, these 
modifications play crucial roles in DNA repair, replication and the regulation of chromosome 
conformation (Kourzarides et al., 2007). Indeed, the role of ubiquitination in pathology 
(Maragoui et al., 2015), as well as SUMOylation in cancer and neurodegenerative diseases 
has recently been highlighted (Eifler & Vertegaal, 2015).  To date it remains unclear as to 
why there is a relative lack of information regarding these modifications. However, authors 
have postulated many theories including the relative infrequency with which these 
modifications occur (Portela & Esteller, 2010), their poorly characterised role in disease 
(Montecino et al., 2015) and the absence of therapeutic inhibitors (Kelly et al., 2010). It 
appears inevitable that future research will demonstrate cross-talk and interplay between 
methylation, acetylation and other histone modifications as previously illustrated by the 
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balancing cellular effects of histone methylation and phosphorylation in controlling gene 
expression (Daujat et al., 2005). 
 
1.2.1.3     Other epigenetic modifications 
In addition to DNA methylation and a range of histone modifications the position of the 
nucleosome on the cellular DNA is critical for regulating both gene and noncoding RNA 
expression. 
 
1.2.1.3.1     Nucleosome positioning 
The nucleosome structure provides a physical barrier to transcription factors and associated 
co-mediator’s gaining direct access to the DNA, while the nucleosome’s position within 
certain regulatory genomic regions also creates an environment to permit or prevent 
transcription (Portela & Estrella, 2010). To enable dynamic access to the DNA, large 
macromolecular families called chromatin remodelling complexes, move, destabilise and 
restructure nucleosomes in a manner dependent on ATP hydrolysis, exerting a repressive or 
permissive transcriptive affect often in combination with HDACs (Clapier & Cairns, 2009). 
Epigenetic interactions between DNA methylation (Harikrishnan et al., 2005) and histone 
modifications (Wysocka et al., 2006) at specific genomic loci appear to destabilise the 
nucleosomes location, regulating the complex remodelling activity, which subsequently 
alters transcription factor access and associated gene expression  (Bourachot et al., 2003). 
Although for the purposes of illustrating the range of epigenetic modifications, nucleosome 
positioning is considered a separate category, it is apparent that the dynamics of 
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nucleosome position are orchestrated by a network of other epigenetic influences (Zentner 
& Henikoff, 2013). 
 
1.2.1.3.2     Non-coding RNA 
Non-coding RNA (ncRNA) molecules which are transcribed from DNA, but are not translated 
into a protein, are considered key regulators of epigenetically controlled gene expression 
(Kelly et al., 2010; Lian, 2015). Within the ncRNA family, selected types are involved in 
facilitating the epigenetic control of gene expression and are sub-classified as short-ncRNAs 
(sncRNAs), which include microRNA (miRNA), small interfering RNA (siRNA), and long-
ncRNAs (lncRNAs) (Mercer & Mattick, 2013). Over the last 10 years, the knowledge of these 
ncRNAs, in particular miRNA, has developed in relation to; i) epigenetic control due to their 
dysregulation in diseases such as cancer (Chawla et al., 2015), ii) regulation of epigenetic 
mechanisms, such as DNA methylation (Fabbri et al., 2007) and iii) expression, which 
conversely, is regulated by epigenetic modifications (Saito et al., 2006). Additionally, lncRNAs 
have also been shown to epigenetically modulate chromatin architecture by recruiting and 
binding chromatin-modifying proteins to specific genomic sites (Khalil et al., 2009), while 
also guiding proteins, such as histone methyltransferases, to those sites (Nagano et al., 2008; 
Guttman et al., 2011). Notably, recent studies have begun to demonstrate the importance of 
miRNA expression and gene expression regulation within pulpal mineralisation responses 
(Heair et al., 2015; Sun et al., 2015). 
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1.2.1.4     Stem cell epigenetics  
Classically, ESCs exhibit an open chromatin structure characterised by relatively low levels of 
DNA methylation and high levels of histone acetylation (Mohammad & Baylin, 2010). 
Following specialised cell lineage commitment and differentiation, the chromatin is modified 
to a more tightly bound conformation with reducing levels of acetylation and increasing 
levels of DNA methylation (Surani et al., 2007). It is now evident that ESCs are maintained in 
a self-renewing state by a complex network of transcription factors (Jaenisch & Young, 
2008), while differentiation and developmental potential are under epigenetic control 
(Meissner, 2010). During differentiation, the pluripotency genes Oct4 and Nanog, are 
repressed (Yamanaka & Blau, 2010), an effect which is mediated initially by histone 
modifications, with the downregulation maintained and cell reprogramming prevented, by 
DNA methylation events (Feldman et al., 2006).  
While it was considered that DNA cytosine methylation occurred exclusively at CpG 
islands, recent studies noted that up to one-quarter of all ESC methylation was identified in a 
non-CG context (Lister et al., 2009). Indeed, the observed pattern of non-CG methylation 
disappeared when differentiation processes were induced in ESCs supporting a crucial role 
for methylation in determining cell fate (Lister et al., 2009). Further characterisation of 
epigenetic modifications in ESCs has identified hypermethylation at 3% of promoter regions 
in CpG islands, notably in developmental genes such as Rhox2 (Fouse et al., 2008). It has 
been proposed that although global methylation levels of CpG may be similar between cell 
types, the distributions of methylation marks in ESCs are unlike any other cell type (Meissner 
et al., 2008). Other epigenetic modifications are also important regulators of SC function and 
self-renewal with HDAC activity and acetylation status vital to the self-renewal capabilities of 
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mesenchymal SCs (Romagnani et al., 2007; Lee et al. 2009) by maintaining the expression of 
key pluripotent transcription factors (Jamaladdin et al., 2014). Acetylation and methylation 
marks in SCs are controlled by cellular mediators, including the polycomb and trithorax 
protein complexes, which occupy ESC gene promoter sites and catalyse specific histone 
modifications (Guenther & Young, 2010; Brien et al., 2012).  
Recently, interest in the epigenetic control of DPSC behaviour has led to the 
suggestion that dental developmental anomalies, such as dentine dysplasia and 
dentinogenesis imperfecta, may be related to epigenetic modifications present during 
odontoblast differentiation (Sun et al., 2015). However, current research approaches are 
preliminary and have not, to date, analysed pure or enriched SC populations (Cardoso et al., 
2014). In a recent SC study, epigenetic states and related differentiation profiles were 
analysed in SC populations of DPSCs and dental follicle progenitor cells (DFPCs), by their 
expression of odontogenic genes, including dentine sialophosphoprotein (DSPP) and dentine 
matrix protein-1 (DMP-1). Transcript levels were epigenetically-suppressed in DFPCs, while 
osteogenic stimulation in vitro demonstrated significant mineralisation increases only in 
DPSCs (Gopinathan et al., 2013). Interestingly, a highly dynamic histone modification 
response was demonstrated in mineralising DFPCs, but not in DPSCs, with DPSCs also 
expressing relatively high levels of the pluripotency-associated transcripts, Oct4 and Nanog. 
It was concluded that these two neural crest-derived SC populations were distinguished by 
epigenetic repression of dentinogenic genes with dynamic histone enrichment in DFPCs 
during mineralisation. The study highlighted the potential important role of epigenetic 
control within the pulp’s terminal differentiation processes.  
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1.2.1.5     Epigenetic modifications as therapeutic targets in the dental pulp 
For the biologically-based endodontic procedures of direct pulp capping and partial 
pulpotomy, to be successful, an environment conducive to tissue repair must be established. 
Furthermore, inflammatory control as well as the promotion of mineralisation, angiogenesis 
and neurogenesis are all necessary to enable effective repair and healing (Grando Mattuella 
et al., 2007; Cooper et al., 2010). Potentially, epigenetic-modifying agents targeting DNA 
methylation and histone acetylation could play a role in regenerative endodontics as they 
have previously been shown to be effective in reducing inflammation, promoting 
mineralisation and modulating regenerative processes in a range of cell types (Shanmugam 
& Sethi, 2013; Gordon et al., 2015; Zhang et al., 2015). Indeed, epigenetic modifications 
present attractive therapeutic targets due to their association with disease and also because 
they are relatively easy to reverse pharmacologically (Kelly et al., 2010; Gordon et al., 2015). 
Within dentistry, it has been postulated that the epigenetic reprogramming which 
accompanies the viral reprogramming of somatic cells to induced pluripotent SCs (iPSCs) 
(Takahashi & Yamanaka, 2006; Huangfu et al., 2008), may prove an important tool for 
wound-healing or regeneration in periodontal tissues (Barros & Offenbacher, 2009 & 2014). 
For the reasons described above, epigenetic modification is an area of significant interest 
within periodontology (Grover et al., 2014) and endodontics (Duncan et al., 2011)  
The enzymes that regulate epigenetic chromatin modifications including 
methyltransferases, demethylases, HATs and HDACs, are of particular therapeutic interest. 
HDACs have been demonstrated to be a particularly attractive target as they have been 
associated with the regulation of mineralisation and developmental cellular processes 
(Gordon et al. 2015), while also being readily inhibited pharmacologically (Richon et al., 
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1996). Eighteen human HDACs have been identified, which have been categorised into four 
classes, with classes 1, 2, and 3 containing zinc dependent enzymes (Gregoretti et al., 2004). 
HDAC classes exhibit different cellular locations (Montgomery et al., 2007), tissue 
expressions (Klinz et al. 2012) and are associated with different cellular processes (de Ruijter 
et al., 2003, Witt et al., 2009, Jamaladdin et al., 2014).  Histone deacetylase inhibitors 
(HDACis) also represent exciting therapeutic candidates as their alterations of gene 
expression patterns modulate intracellular signalling, with subsequent effects on cell 
phenotype. The medical literature also reports that HDACis are associated with anti-
inflammatory effects, pro-mineralisation, increased SC differentiation and improved 
regenerative responses (Halili et al., 2009; Xu et al., 2009; Wang et al., 2010). Consequently, 
HDACis have the potential to enhance tertiary dentinogenesis by influencing the cellular and 
tissue processes critical to the success of vital pulp treatment. Furthermore, HDACi-induced 
modifications occur at nano to micro molar concentrations with minimal side effects and 
therefore, may offer the ability to develop an easily placed, inexpensive bio-inductive dental 
restorative material. 
 
1.3 Hypotheses 
The hypotheses to be examined in the current investigations are that:  
 HDACis can positively affect cell proliferation and differentiation to accelerate 
mineralisation events in dental pulp-derived cells. 
 HDACis induce reparative responses in primary DPCs at concentration and dose levels 
which do not stimulate significant anti-proliferative, apoptotic or necrotic effects.  
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 The mechanisms behind the regenerative properties of a specific HDACi, namely 
suberoylanilide hydroxamic acid (SAHA), relate to transcriptomic changes which 
modulate selected mineralisation-associated pathways and the novel markers 
identified interact with SAHA to promote and augment pulpal reparative processes. 
 HDACis remove or alter the smear layer remaining after dentine preparation owing 
to their acidic nature. 
 HDACi solubilise a range of dentine matrix components (DMCs), which may promote 
bioactive and clinically relevant dental repair responses. 
 
1.4 Aims and objectives 
The overall aim of this body of work was to assess the ability of one group of epigenetic-
modifying agents, namely HDACis, to induce mineralisation and promote reparative 
responses in DPCs. The specific objectives to be examined include to: 
 Review the literature in relation to HDACi cellular function, focusing on HDACi-
induced effects including inflammation control, mineralisation-induction, and wound 
repair, which may be beneficial for therapeutic application within the pulp. 
 Summarise the current knowledge of all epigenetic-modifying agents, in particular 
HDACis, to consider their role in SC differentiation, de-differentiation and 
reprogramming in the context of the development of novel regenerative therapies 
for the dentine-pulp complex. 
 Investigate the effects of two pan-HDACis, namely trichostatin A (TSA) and valproic 
acid (VPA), on cell viability, cell cycle and mineralisation responses in dental-papillae 
derived cell-line cultures.  
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 Analyse HDACi-induced mineralisation responses in primary DPC cultures, focusing 
on cell viability, growth, apoptosis mineralisation-associated gene/protein marker 
expression.  
 Identify a response range of HDACi concentrations and doses in primary DPCs in line 
with previous studies (Ungerstedt et al., 2005; Lee et al., 2010) where significant 
differences between transformed and primary cell culture responses to HDACis were 
reported.  
 Determine the mechanisms by which the clinically-approved HDACi, SAHA, promotes 
regenerative processes in primary DPCs using high-throughput transcriptomic 
analyses, prior to pathway analysis, molecular validation and pharmacological 
inhibition approaches.  
 Review the literature on the roles of bioactive molecules located in the dentine-pulp 
complex, their potential contribution to pulpal reparative events after injury and as a 
part of regenerative therapeutic strategies. 
 Compare the solubilisation of a range of DMCs using three HDACis with characterised 
extractants, to identify conditions which may favour bioactive dentine-pulp repair 
responses if HDACis were to be applied clinically in regenerative endodontic 
treatment protocols. 
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CHAPTER 2 
 
PUBLICATION 1: REVIEW 
 
Duncan HF, Smith AJ, Fleming GJP, Cooper PR. (2011). HDACi: cellular effects, 
opportunities for restorative dentistry. J Dent Res 90:1377-1388.  
 
In the context of the planned body of work, the medical and cell biology literature was 
reviewed in relation to the influence of epigenetic-modifications, histone acetylation, HDAC 
enzymes and the use of one specific group of epigenetic modifying agents, HDACis, in 
altering cell phenotype. The bulk of the review focussed on the role of HDACis as a 
modulator of pleiotropic cellular processes, such as differentiation, proliferation, apoptosis, 
reactive oxygen species generation, neurogenesis and angiogenesis. Thereafter, the 
potential translational benefits of the HDACi-induced effects specific to pulp tissue injury 
and repair were reviewed to include inflammatory control, mineralisation and tissue 
engineering, pain and stem cell/regenerative effects. HDACi associated side-effects, barriers 
to clinical implementation and the need for future research were also considered. 
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CHAPTER 3 
 
PUBLICATION 2: REVIEW  
 
Duncan HF, Smith AJ, Fleming GJP, Cooper PR. (2016). Epigenetic modulation of dental 
pulp stem cells: implications for regenerative endodontics. Int Endod J doi: 
10.1111/iej.12475. [Epub ahead of print] 
 
During the course of these studies, it was evident that epigenetic modifying agents and 
HDACi in particular, could exert differing effects on a range of cell types. Primary cells were 
generally more resistant to the effects of HDACis than transformed cells, while notably stem 
cell (SC) populations reacted differently from adult differentiated cell populations. Critically, 
it became evident that SC commitment, in either self-renewal or differentiation, was 
controlled at least in part by epigenetic signalling and marks. As a result, the current 
knowledge of HDACi, and other epigenetic-modifying agents, in altering SC differentiation, 
de-differentiation and reprogramming was reviewed in the context of the development of 
novel regenerative therapies for the dentine-pulp complex. 
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CHAPTER 4 
 
PUBLICATION 3: ORIGINAL SCIENTIFIC MANUSCRIPT 
 
Duncan HF, Smith AJ, Fleming GJP, Cooper PR. (2012). Histone deacetylase inhibitors 
induced differentiation and accelerated mineralization of pulp-derived cells. J Endod 
38:339-345.  
Based on the previous review of HDACi-induced cellular effects (Chapter 2), it was 
hypothesised that HDACis would positively affect cell proliferation, promote differentiation 
and accelerate mineralisation events in a dental papillae-derived cell line (MDPC-23). The 
experimental methodologies were specifically designed to investigate the cellular effects of 
two pan-HDACis (TSA and VPA), applied to cell cultures at a range of relatively low 
concentrations. Cell viability was assessed by cell counting and trypan blue exclusion, cell 
cycle and apoptosis were analysed by immunocytochemical staining and high content 
analyses, while cellular mineralisation responses were investigated by quantitative Alizarin 
red staining and reverse transcriptase polymerase chain reaction (RT-PCR).  
 
Basic Research—BiologyHistone Deacetylase Inhibitors Induced Differentiation
and Accelerated Mineralization of Pulp-derived Cells
Henry F. Duncan, BDS, MClin Dent,* Anthony J. Smith, PhD,‡ Garry J.P. Fleming, PhD,†
and Paul R. Cooper, PhD‡Abstract
Introduction: Histone deacetylase inhibitors (HDACis)
alter the homeostatic balance between 2 groups of
cellular enzymes, histone deacetylases (HDACs) and
histone acetyltransferases (HATs), increasing transcrip-
tion and influencing cell behavior. This study investi-
gated the potential of 2 HDACis, valproic acid (VPA)
and trichostatin A (TSA), to promote reparative
processes in pulp cells as assayed by viability, cell cycle,
and mineralization analyses. Methods: VPA (0.125–5
mmol/L) and TSA (12.5–400 nmol/L) were applied to
a pulp-derived cell population and compared with un-
supplemented controls. Cell proliferation and viability
were evaluated by trypan blue staining and cell count-
ing, whereas cell cycle and apoptosis were analyzed
by immunocytochemical staining with antibodies for
p53, phosphorylated p53, Bcl-2 homologous antago-
nist/killer (BAK), caspase-3 and p21WAF1/CIP, and DNA
staining with Hoechst 33342. For mineralization anal-
ysis, cultures were stained with Alizarin red and quanti-
fied spectrophotometrically. Relative gene expression
levels of mineralization associated markers were
analyzed using reverse-transcriptase polymerase chain
reaction. One-way analysis of variance and Tukey post
hoc tests were applied to the data (P < .05). Results:
VPA and TSA reduced cell proliferation dose depen-
dently with no significant effect on cell viability except
at 400 nmol/L TSA. The transcription factor p21WAF1/
CIP was significantly increased at the highest concentra-
tion of TSA but not VPA. Significant increases (P < .05)
in the apoptosis marker protein active caspase-3 and cell
cycle alterations were only evident at the maximum
concentrations of TSA/VPA, whereas HDACi-induced
mineralization per cell was stimulated dose dependently
with a significant increase in the expression of the
dentinogenic-associated transcript, dentine matrix
protein-1. Conclusions: These results indicate that
HDACis are capable of epigenetically modulating pulp
cell behavior, signifying their therapeutic potential forFrom the *Division of Restorative Dentistry and Periodontology
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JOE — Volume 38, Number 3, March 2012augmenting biomaterials, and stimulating regenerative responses in the damaged
pulp. (J Endod 2012;38:339–345)
Key Words
Dental pulp cells, dental restorative material, epigenetics, histone deacetylase inhibi-
tors, regeneration
Exciting opportunities exist for the development of a new generation of dentalmaterials that are functionally modified to act on various biological processes
thereby stimulating regenerative events (1, 2). Such materials may target tissue
injury-associated events using antioxidants (N-acetyl cysteine) (2–4) or may
directly stimulate regeneration by the addition of growth factors (5–7). However,
targeting cell nuclear function offers a novel mode of action because acetylation
of DNA-associated histone and non-histone proteins influences gene expression
and induces various cellular processes (8–10). Acetylation is regulated by the
cellular enzymes, histone acetyltransferases (HATs), and histone deacetylases
(HDACs) (11). HAT activity relaxes the structure of chromatin rendering it transcrip-
tionally active, thereby increasing gene expression, whereas HDAC represses
transcription (12).
Histone deacetylase inhibitors (HDACis) modify the balance between HATs and
HDACs, leading to the accumulation of acetylated proteins with associated transcriptional
and cellular effects, thereby influencing proliferation, differentiation, and apoptosis (11,
13). A host of natural and synthetic HDACis exist, including valproic acid (VPA) and
trichostatin A (TSA), which have similar nuclear action but differ in chemical structure
and selectivity (13–15). Although originally investigated as prodifferentiation adjuncts
in the treatment of cancer cells (11, 13), HDACi-mediated effects also provide novel ther-
apeutic approaches in normal cells and are currently being investigated for application in
bone engineering (16), inflammatory diseases (17), and stem cell engineering (18).
HDACis alter cell phenotype by a range of mechanisms, including modulation of gene
expression and intracellular signaling, indicating a potential therapeutic role in
promoting reparative processes in pulp cells (10). Specifically, the application of VPA,
TSA, and other HDACis increases in vitro expression of osteogenic-related markers in
primary cells and cell lines, including alkaline phosphatase (16, 19), collagen-1a,
osteocalcin, osteopontin, and bone sialoprotein (20, 21). Concomitantly, HDACis
accelerate osteoblast differentiation and mineralization processes (16, 20, 21). TSA
has been shown to epigenetically up-regulate stem cell markers in regenerative amputa-
tion sites (22). VPA and other HDACis have been shown to reduce circulating proinflam-
matory cytokine production (15, 17) and further control inflammatory processes byand †Material Science Unit, Division of Oral Biosciences, Dublin Dental University Hospital, Trinity
try, University of Birmingham, St Chads Queensway, Birmingham, United Kingdom.
Restorative Dentistry and Periodontology, Dublin Dental University Hospital, Trinity College Dublin,
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modulating the transcriptional accessibility of the nuclear factor-kappa B
(NF-kB) gene (23).
The promotion of tissue regeneration after dental pulp damage re-
sulting in tertiary dentinogenesis is a key goal of vital pulp therapy (5).
HDACis have not yet been investigated within restorative dentistry but
could potentially address current vital pulp treatment limitations asso-
ciated with inflammation (24) and unpredictable mineral deposition
(25). Their incorporation or adjunctive use with dental restorative
approaches may subsequently facilitate the development of more tar-
geted ‘‘regenerative restorative biomaterials’’ (1, 2), which is similar
to previous work that has included antibacterials and antioxidants
(26, 27). Based on previous studies, we hypothesized that a synthetic
and natural HDACi, VPA (15), and TSA (14) could positively affect
cell proliferation, cell differentiation, and cell cycle, leading to acceler-
ated mineralization events in dental pulp-derived cells.
Materials and Methods
HDACis
A stock 1 mol/L VPA (2-propylpentanoic acid sodium salt)
(Sigma-Aldrich, Arklow, Ireland) in phosphate-buffered saline
(PBS) was diluted with supplemented cell culture medium; 5 mmol/
L TSA (7-[4-(dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxo-
2,4-heptadienamide) (Sigma-Aldrich) in dimethyl sulfoxide was
diluted in PBS before supplementation in culture medium.
Cell Culture
The murine dental pulp–derived cell line (MDPC-23) was used
(28). Cells were grown in high glucose (4.5 g/L) Dulbecco modified
Eagle medium (DMEM) (Biosera, East Sussex, UK) supplemented with
2 mmol/L L-glutamine, 1% penicillin/streptomycin (10,000 U/mL
penicillin with 10,000 mg/mL streptomycin), and 10% (v/v) fetal
calf serum (Biosera) at 95% relative humidity in a 5% CO2 atmosphere
at 37C.
Evaluation of Cell Proliferation and Cell Viability
Cells were seeded (5  104) on 6-well culture dishes (Sarstedt,
Wexford, Ireland) and cultured in 2 mL supplemented DMEM. At 24
hours, VPA (0.25 mmol/L, 0.5 mmol/L, 1 mmol/L, 3 mmol/L, and
5 mmol/L) and TSA (12.5 nmol/L, 25 nmol/L, 50 nmol/L, 100 nmol/
L, 200 nmol/L, and 400 nmol/L) were supplemented in cultures and
incubated for a further 72 hours. The positive control samples con-
tained cells cultured in DMEM not supplemented with HDACis, whereas
the negative control samples contained no cells. Cells were detached
with Hank’s balanced salt solution containing 2.5 g/L trypsin and 0.2
g/L EDTA and stained with 0.4% trypan blue before cell counting and
viability assessment using a standard hemocytometer. Cell proliferation
for each experimental HDACi concentration was calculated and charted
as % control.
Cell Cycle and Apoptosis
To determine the influence of HDACi on cell cycle and apoptosis,
high-content analysis (HCA) was performed. Cells were seeded (4 
103) in 96-well plates (Sigma-Aldrich, Arklow, Ireland) for 24 hours
before culture in supplemented DMEM containing TSA (50 nmol/L,
100 nmol/L, 200 nmol/L, and 400 nmol/L) or VPA (0.5 mmol/L,
1 mmol/L, 3 mmol/L, and 5 mmol/L) for 24 and 48 hours. Positive
controls contained cell cultures not supplemented with HDACi
(0 nmol/L/mmol/L concentration); negative controls contained no
cells. Cells were fixed in 1% formaldehyde in PBS for 30 minutes and
processed (Imagen Biotech, Manchester, UK) by permeabilization
and stained with antibodies (diluted to 500 mg/mL in digitonin/PBS340 Duncan et al.solutions), anti-BAK (Cat# AM03; Merck, Darmstadt, Germany), active
caspase 3 (Cat# ab13847; Abcam, Cambridge, UK), p21WAF1/CIP (Cat#
PN8400602; Thermo Fisher Scientific, Leicestershire, UK), p53 (Cat#
PN8400602, Thermo Fisher Scientific), and phosphorylated p53
(Cat# PN8400702, Thermo Fisher Scientific). Immunoreactions were
visualized using 2 fluorophore-conjugated secondary antibodies, goat
antimouse 488, and goat antirabbit 594 (Cat# 11001 and 11037
respectively; Invitrogen, Paisley, UK). For cell cycle analysis, DNA was
stained with Hoechst 33342 at 2.5mg/mL, and the% of each component
of the cell cycle was recorded (Invitrogen). Cultures were analyzed on
an Arrayscan using a compartmental analysis algorithm (Cellomics,
Thermo Fisher Scientific). The number of cells expressing the marker
protein was recorded as a percent of the total number of cells scanned.
Mineralization Assay
Cells were seeded (5 104) on 6-well culture dishes and cultured
in 2 mL supplemented DMEM for 72 hours until 60% to 70% confluent
before exposure to HDACi-supplemented mineralizing medium (DMEM
supplemented with 50 mg/mL ascorbic acid, 0.1 mmol/L dexametha-
sone, and 10 mmol/L b-glycerophosphate  VPA or TSA concentra-
tions) for the duration of the experiment. Cultures were incubated
for 1, 4, 7, and 10 days with regular mineralizing media changes. For
mineralization analysis, 10-day cultures were washed 3  5 minutes
in PBS and fixed in 10% formaldehyde for 15 minutes, washed with
distilled water, and then stained with 1.37% (w/v) Alizarin red S (Milli-
pore, Cork, Ireland) (pH = 4.2) for 15 minutes at room temperature.
The stain was solubilized and quantified spectrophotometrically at 405
nm (29). For the time-course study, cell numbers were determined at 1,
4, 7, and 10 days (as for proliferation and viability studies); after
detachment, trypan blue staining and standard counting using a hemo-
cytometer were performed. Mineral production per cell data for VPA
and TSA were based on quantification of Alizarin red S stain (in
mmol/L) extracted from each experimental well and the corresponding
10 day time-course data for each HDACi.
Reverse-transcriptase Polymerase Chain Reaction
Cells were seeded (5 104) onto a 6-well culture dish and 2 mL
supplemented mineralizing medium containing 1 mmol/L VPA or 100
nmol/L TSA were added after 24 hours. HDACi concentrations used
were determined from the optimum results of the proliferation, viability,
cell cycle, and mineralization studies. Positive controls contained no
HDACis, whereas negative controls were cultured only in supplemented
DMEM. Cultures were incubated for a further 72 hours, detached with
trypsin/EDTA, homogenized for 30 seconds using a T10 basic S2-Ultra-
Turrax tissue disrupter (IKA, Staufen, Germany), and RNA extracted
using the RNeasy mini kit (Qiagen, West Sussex, UK) before elution
in 30 mL of sterile water. RNA concentrations were determined spectro-
photometrically at 260 nm, and RNA was converted into single-stranded
complementary DNA using the Omniscript kit (Qiagen) and oligo-dT
primer (Ambion; Applied Biosciences, Dublin, Ireland). Synthesized
complementary DNA was concentrated and purified by centrifugation
with Microcon YM-30 filters (Millipore, Cork, Ireland) and comple-
mentary DNA concentrations determined spectrophotometrically.
Semi-quantitative reverse-transcriptase polymerase chain reaction
analysis was performed for mouse genes using the following
specific primers: dentine matrix phosphoprotein-1 (DMP-1) (F)-5’
CCCATCACCATCTTCCAGGAGC 3’/(R)-5’ CCAGTGAGCTTCCCGTTCAGC,
bone morphogenic protein-4 (BMP-4) (F)-5’ CAGGGCTTCCACCGTA-
TAAA/ (R)-5’ ATGCTTGGGACTACGTTTGG, and transforming growth
factor beta-1 (TGF-b-1) (F)-5’ CTGTCCAAACTAAGGCTCGC/ (R)-5’
CGTCAAAAGACAGCCACTCA normalized to glyderaldehyde-3-phosphateJOE— Volume 38, Number 3, March 2012
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dehydrogenase (GAPDH) (F)-5’ CCCATCACCATCTTCCAGGAGC/ (R)-5’
CCAGTGAGCTTCCCGTTCAGC (Invitrogen). Each polymerase chain reac-
tion included 12.5 mL REDTaq ReadyMix Polymerase Chain Reaction
Mix (with MgCl2) (Sigma-Aldrich), 0.5 mL forward/reverse primer,
10 mL molecular grade water, and 50 ng of template complementary
DNA. Polymerase chain reactions were performed using the GS-1
G-Storm thermal cycler (G-Storm, Surrey, UK) and subjected to the
designated number (20-45) of amplification cycles in which a typical
cycle was performed at 95C for 20 seconds, 60C for 20 seconds,
and 72C for 20 seconds. After thermal cycling, amplified products
were electrophoresed on a 1.5% agarose gel supplemented with gel
red (Biotium, Hayward, CA) and visualized under ultraviolet light
with the AlphaImager-Mini system (Alpha Innotech/Cell Biosciences,
Santa Clara, CA). Captured gel images were imported into AlphaView
image analysis software (Alpha Innotech/Cell Biosciences) for densito-
metric analysis. The volume density of amplified products was deter-
mined and normalized to GAPDH intensity levels. The averaged values
for each group were calculated and expressed as a percentage of the
highest normalized individual band density obtained for each DMP-1,
BMP-4, and TGF-b1 transcript.
Statistical Analysis
One-way analyses of variance and Tukey post hoc tests were used
(P < .05) for cell proliferation, cell viability, cell cycle, apoptosis
markers, mineralization per cell data, and reverse-transcriptase poly-
merase chain reaction to determine the influence of HDACi concentra-
tion on the cells using SigmaStat 12.0.1 software (SPSS Inc, Chicago,
IL). Linear regression analyses were applied to the mineralization per
cell data for the examination of the dose-dependent effects of VPA
and TSA.
Results
Cell Proliferation and Cell Viability
Cell proliferation was significantly inhibited by treatment for 3 days
with VPA (P < .003) and TSA (P < .001) compared with control unsti-
mulated cultures at all concentrations, with the exception of 0.25mmol/
L VPA (P= .152) and 12.5 nmol/L TSA (P = .066) (Fig. 1A and B). Cell
viability (trypan blue exclusion) was not significantly reduced with VPA
(P > .299) or TSA (P > .188) with the exception of 400 nmol/L TSA
(P = .011) (Fig. 1A and B) when compared with the control.
Cell Cycle and Apoptosis
At 24 and 48 hours, there were no significant changes in nuclear
p53 and BAK levels with VPA and TSA (all P > .05) compared withFigure 1. Proliferation and viability of pulp-derived cells cultured in the presence o
measurement (SEM). Asterisks and > denote a statistically significant difference (
control. The experiment was performed in duplicate on 3 separate occasions.
JOE — Volume 38, Number 3, March 2012untreated cells (data not shown). Phosphorylated p53 showed a signif-
icant increase in expression at 24 hours (P< .0001) but not at 48 hours
(P> .054) for VPA (Fig. 2A). No significant changes in expression at 24
hours (P > .059) or 48 hours (all P > .816) for TSA were evident
(Fig. 2B). No difference in transcription factor p21 expression was
shown at 24 hours (P > .999) or 48 hours (P > .927) for VPA or
48 hours for TSA (P = 1.0) (Fig. 2C and D). A significant increase
in p21 expression at 24 hours was identified at 400 nmol/L TSA
(P< .0001) and a significant increase in active caspase-3 was observed
with 5 mmol/L VPA at 24 hours (P = .017) (Fig. 2E) and 400 nmol/L
TSA at 24 hours (P = .038) and 48 hours (P < .0001) (Fig. 2F). Cell
cycle analysis at 48 hours indicated minimal alteration with HDACis
(P > .124) although there was a decrease in cells in the G2 phase
and G2/S after the administration of 5 mmol/L VPA (P = .003)
(Fig. 2G) and 400 nmol/L TSA (P = .002/.013), respectively (Fig. 2H).
Mineralization
Quantitative measurement of Alizarin red S stain showed that
mineralization was significantly increased by treatment for 10 days
with 3 mmol/L VPA (P = .001) and with 100 nmol/L (P = .007) and
200 nmol/L (P = .008) TSA (Fig. 3A and B). Mineralization time-
course analysis showed a significant reduction in the cell number at 4-
days with VPA concentrations of 0.25 mmol/L (P = .035), 0.5 mmol/L
(P = .008), and 1 mmol/L (P = .002) and 10 days with 1 mmol/L VPA
(P = .007) (Fig. 3C). Additionally, a significant reduction in cell
numbers was observed at 4, 7, and 10 days after 3 mmol/L VPA admin-
istration (P < .004). A significant reduction in cell numbers at 4, 7, and
10 days for all concentrations above 12.5 nmol/L TSA (P < .035) with
a significant reduction at 10 days for 12.5 nmol/L TSA (P = .008) was
evident when compared with untreated cells (Fig. 3D). No significant
difference in cell number for VPA or TSA at 1 day (P > .095) was iden-
tified for all concentrations investigated (Fig. 3C and D).
At 10 days, a significant increase in mineralization per cell was
evident for all HDACi concentrations with the exception of 0.125
mmol/L VPA (P = .968) and 12.5 nmol/L TSA (P = .346) when
compared with the untreated cells (Fig. 3E and F). VPA and TSA signif-
icantly increased mineralization per cell (P < .022) in a dose-
dependent manner manifest as positive linear regression slopes
(R2 values >.86) (Fig. 3E and F).
Gene Expression
The relative expression of DMP-1 was significantly increased in
VPA- (P< .03) and TSA- (P< .01) treated cells compared with the posi-
tive and negative control cultures (Fig. 4A and B). BMP-4 levels werer absence of (A) VPA and (B) TSA. Data represented as mean standard error
P < .05) between the experimental groups (VPA and TSA) and the untreated
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Figure 2. The expression of proliferation/apoptosis protein markers and cell cycle analysis in pulp-derived cells cultured in the presence or absence of (A, C, E,
and G) VPA and (B, D, F, and H) TSA. All data represented as mean SEM. *A statistically significant difference (P < .05) between the experimental groups (VPA
and TSA) and the untreated control. Experiments were performed in triplicate on 3 separate occasions.
Basic Research—Biologysignificantly increased in the VPA-treated cells compared with the nega-
tive control (P = .027) but not the positive control cultures (P = .09)
(Fig. 4C). The relative expression levels of TGF-b1 (Fig. 4D) was signif-
icantly increased in the positive control (P = .017) and VPA-treated
(P = .026) cells compared with the negative control only.342 Duncan et al.Discussion
The present study indicates a novel epigenetic role for HDACis in
accelerating regenerative pulp mineralization without affecting cell
viability or inducing cell death. HDACis significantly reduced cell prolif-
eration at low concentrations (0.5 mmol/L VPA and 25 nmol/L TSA),JOE— Volume 38, Number 3, March 2012
Figure 3. Mineralization per cell analysis in pulp-derived cells cultured in the presence and absence of VPA/TSA-supplemented osteogenic medium. (A) VPA and
(B) TSA mineralization assay data represented as mean  SEM and statistically significant differences (P < .05) between the experimental and control plate are
marked (*). (C) VPA and (D) TSA time-course study data.Statistical significance (P < .05) at 4 days. ‡Statistical significance at 7 days. *Statistical significance at
10 days. (E) VPA and (F) TSA mineral production per cell data represented as mean SEM. *Statistically significant differences (P < .05) between the experimental
and control plate. All experiments were performed in duplicate on 3 separate occasions.
Basic Research—Biologywith greater than 85% cell survival showing that pulp cells are sensitive
to HDACi-mediated growth inhibition. A progressive significant reduc-
tion in cell proliferation was evident with an increasing HDACi concen-
tration to concentrations of 5 mmol/L VPA and 400 nmol/L TSA,
indicating a biphasic mode of action and cellular sensitivity. Previously,
normal (16) and transformed cells (30) have shown similar HDACi-
mediated reduction in proliferation, with HDACi concentration effects
varying depending on cell type and the HDACi applied (21, 31).
HDACi-induced growth inhibition, principally of transformed
cells, has been reported to be commonly mediated via induction of
the cyclin-dependent kinase inhibitor p21WAF1/CIP1 (30, 32), either
via p53-dependent or independent pathways (33).We observed a signif-
icant increase in p21 levels only at the highest concentration of TSA
(400 nmol/L), which was not evident with VPA, which is suggestive of
different molecular kinetics or pathways for each HDACi within this
pulp-derived cell population. Alternatively, because the HCA technique
only captures a ‘‘snapshot’’ of cell activity (24 and 48 hours), these data
may indicate that p21 levels are not chronically increased. Notably, the
transcription factor p53 was not increased with VPA or TSA, suggesting
that a p53-independent mechanism of growth inhibition is operative inJOE — Volume 38, Number 3, March 2012this cell line (33). Interestingly, however, a significant increase in phos-
phorylated p53 was evident for 5 mmol/L VPA, indicating that a p53-
dependent mechanism may still function in orchestrating pulpal cell
growth inhibition.
In the current study, despite a progressive reduction in prolifera-
tion, VPA and TSA had no significant impact on cell viability (except at
400 nmol/L TSA), showing that HDACi did not induce pulp cell death.
Similarly, osteoblast viability was also not reportedly affected by VPA or
TSA over a wide range of concentrations (20, 21). The significant
increase in active caspase-3 expression at the highest HDACi concentra-
tion (5 mmol/L VPA and 400 nmol/L TSA, respectively) indicated
HDACi-induced apoptosis, which corroborates the reported reduction
in growth and viability at the maximum concentration (34).
Further evidence that VPA and TSA were not inducing cell cycle
arrest in these cells was provided by nuclear Hoechst staining and
HCA, which showed an alteration in the G1/G2 phase although only at
the highest HDACi concentration. However, even at the maximum
concentration applied, there was no evidence of cell cycle arrest.
HDACi-induced cell cycle arrest has previously been shown in neoplasia
studies and at relatively high HDACi concentrations capable of inducingHDACis Affect Pulp-derived Cells 343
Figure 4. Semiquantitative reverse-transcriptase polymerase chain reaction analysis showing differential gene expression in pulp-derived cells in the presence or
absence of VPA and TSA. (A) A gel image showing the expression profile of the housekeeping gene GAPDH and the mineralization/dentinogenic-associated markers
DMP-1, BMP-4, and TGF-b-1. The designated cell cycle numbers for the analyses are shown. Graphs showing the relative expression of (B) DMP-1, (C) BMP-4, and
(D) TGF-b-1 where the data are represented as mean SEM. *Statistically significant differences (P < .05) between the experimental and negative control cultures.
Statistically significant differences between the experimental and positive control cultures at P < .05. The results represent duplicate experiments performed on 2
separate occasions.
Basic Research—Biologyapoptosis (32); however, this arrest is generally not evident in primary
cells and at lower HDACi concentrations used for anti-inflammatory and
mineralization-inductive effects (17, 21, 35).
Because we observed an HDACi-mediated reduction in cell prolif-
eration without an equivalent increase in apoptotic cell death or cell
cycle arrest, we hypothesized that the HDACis were inducing an increase
in cell differentiation. Indeed, cellular differentiation was accelerated by
VPA and TSA in these pulp-derived cells as shown by Alizarin red S stain
quantification, suggesting that as the HDACi reduced growth, mineral-
ized cell (odontoblast-like) differentiation increased dose dependently.
Notably, the acceleration of mineral production in these cells occurred
with a range of HDACi concentrations below those that significantly
reduced viability and induced cell cycle change. Further evidence of
cell differentiation was supported by the significantly increased relative
expression of the odontoblast-related marker DMP-1 and the general
mineralization marker BMP-4 in HDACi-treated cells. The observed
increase in DMP-1 suggests that the suppression of HDAC activity during
odontoblast-like differentiation can accelerate mineralization. Indeed,
HDACis are known to promote differentiation in pluripotent stem cell
populations (18), neural progenitor cells (31), and primary osteo-
blasts (20, 21). Specifically, HDACis stimulate the expression of
osteoblast marker genes in primary and osteoblast cell lines (21);
however, this has not previously been shown in pulp-derived cells.
The authors do accept that previous in vitro studies investigating oste-
oblastic cultures (20, 21) and indeed the currently reported
experiments on pulp-derived cells are limited in their clinical relevance
by the nature of the 2-dimensional monolayer compared with 3-
dimensional tissues. However, the current results provide an exciting
framework for future 3-dimensional experimentation. Although the 2
HDACis tested have different chemical structures, specificities and
potencies, they both exert similar influences on differentiation, suggest-344 Duncan et al.ing that they affect similar HDAC enzymes and the expression of a closely
related array of genes.
The effective delivery of HDACi drugs to the damaged pulp will
require a suitable carrier material. Logically, HDACis could be inte-
grated into existing dental restorative materials similar to the way in
which other agents have been incorporated with and without the assis-
tance of the material manufacturer (2, 26, 36–38). This approach may
be useful for developing a new regenerative restorative material that can
be used in direct contact vital pulp treatment and warrants further
in vitro studies investigating the physical properties of the integrated
material and the stability of HDACi release.
In this study, we showed that 2 HDACis reduce proliferation and
increase mineralization in a dose-dependent manner in pulp-derived
cells while not significantly influencing cell viability and cell cycle.
Notably, the combined increase in mineral per cell and dentinogenic
gene expression indicates that these inhibitors can epigenetically modu-
late the cell encouraging acceleration and odontoblast-like differentia-
tion. Because HDACis are currently being used as novel treatment
approaches in several clinical areas, they represent interesting thera-
peutic candidates for regenerative biomaterials within restorative
dentistry.
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CHAPTER 5 
 
PUBLICATION 4: ORIGINAL SCIENTIFIC MANUSCRIPT 
 
Duncan HF, Smith AJ, Fleming GJP, Cooper PR. (2013). Histone deacetylase inhibitors 
epigenetically promote reparative events in primary dental pulp cells. Exp Cell Res 
319:1534-1543.  
 
The literature highlighted differences between transformed and primary cell responses to 
HDACis (Chapter 2). An HDACi-induced dose-dependent promotion of mineralisation in pulp-
derived cells was demonstrated (Chapter 4) with a significant reductions in cell growth, cell 
viability and cell cycle alteration evident at the higher HDACi concentrations. As a result, it 
was hypothesised that HDACis would induce reparative responses in primary DPCs at 
concentration and dose levels which did not stimulate significant cytotoxic effects. The 
subsequent aim was to replicate and expand the MDPC-23 experimentation to primary DPCs 
by quantitatively analysing mineralisation responses by focusing on a range of assays 
investigating cell viability, cell growth, cell apoptosis and mineralisation-associated 
gene/protein marker expression.  
Available online at www.sciencedirect.comjournal homepage: www.elsevier.com/locate/yexcr
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Application of histone deacetylase inhibitors (HDACi) to cells epigenetically alters their chromatin
structure and induces transcriptional and cellular reparative events. This study investigated the
application of two HDACi, valproic acid (VPA) and trichostatin A (TSA) on the induction of repair-
associated responses in primary dental pulp cell (DPC) cultures. Flow cytometry demonstrated that
TSA (100 nM, 400 nM) signiﬁcantly increased cell viability. Neither HDACi was cytotoxic, although cell
growth analysis revealed signiﬁcant anti-proliferative effects at higher concentrations for VPA
(40.5 mM) and TSA (450 nM). While high-content-analysis demonstrated that HDACi did not
signiﬁcantly induce caspase-3 or p21 activity, p53-expression was increased by VPA (3 mM, 5 mM)
at 48 h. HDACi-exposure induced mineralization per cell dose-dependently to a plateau level (VPA-
0.125 mM and TSA-25 nM) with accompanying increases in mineralization/dentinogenic-associated
gene expression at 5 days (DMP-1, BMP-2/-4, Nestin) and 10 days (DSPP, BMP-2/-4). Both HDACis, at a
range of concentrations, signiﬁcantly stimulated osteopontin and BMP-2 protein expression at 10 and
14 days further supporting the ability of HDACi to promote differentiation. HDACi exert different
effects on primary compared with transformed DPCs and promote mineralization and differentiation
events without cytotoxic effects. These novel data now highlight the potential in restorative dentistry
for applying low concentrations of HDACi in vital pulp treatment.
& 2013 Elsevier Inc. All rights reserved.Introduction
Histone deacetylase inhibitors (HDACi) regulate the acetylation
of DNA-associated proteins and subsequently alter chromatin
architecture, resulting in changes to transcriptional activity [1–3].
Epigenetically-induced HDACi-modiﬁcations have beneﬁcial effects
on tissue repair mechanisms including the promotion of stem cell
recruitment and the induction of differentiation and mineralization
processes [4–6], as well as modulating inﬂammation [7]. Therapeu-
tically, these properties of HDACi could be harnessed to augmentInc. All rights reserved.
, halfergusduncan@hotmaibiologically-driven dental restorative approaches [8,9] with potential
to improve the predictability of healing outcomes. Regenerative
techniques which preserve pulp vitality have recently been empha-
sized [10], however, currently they have poor prognosis [11] poten-
tially in part, due to the failure of materials to control inﬂamma-
tion [12] and enable consistent new matrix deposition [13,14].
Recent studies [15,16] demonstrate that HDACi promote miner-
alization in dental pulp cell lines, suggesting their therapeutic
potential. However, variances were documented in cell resistance
[17,18], cell toxicity [17,18] and inhibitor concentration [17,18]l.com (H.F. Duncan).
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cells. This altered cellular sensitivity has been the basis of multi-
ple studies investigating HDACi as potential anti-cancer agents
[1,3,5], acting by the promotion of cell death pathways in
transformed cell lines [19,20], but not in primary cells
[17,18,21]. Because of these contrasting cellular responses, it is
essential that the effects of HDACi are now investigated in
primary dental pulp cells (DPCs), which provide greater transla-
tional and clinical relevance.
A host of HDACi has been identiﬁed with a subgroup, of mainly
pan-inhibitors, now engaged in clinical trials [1]. Although,
valproic acid (VPA) and trichostatin A (TSA) are considered pan-
inhibitors they have different chemical structures, speciﬁcities
and potencies. However, both have been reported to exert similar
inﬂuences on differentiation suggesting that they affect similar
HDAC enzymes and the expression of a closely related array of
genes [4]. Chemically, the structure of TSA is based around a
hydroxamic acid structure and it is regarded as a general classes I
and II HDAC inhibitor, while VPA possesses a carboxylic acid
functional group and does not inhibit all class II HDAC enzymes
(HDAC6 or HDAC10) [22]. Reported differences in cell behavior in
response to different HDACi are likely to be related to the
speciﬁcity of each inhibitor [1,4,22].
Based on previous studies, we hypothesize that the two HDACis
investigated, VPA and TSA, induce reparative responses in primary
DPCs at concentration levels which do not stimulate signiﬁcant
anti-proliferative, apoptotic or necrotic effects.Material and methods
Primary cell isolation and culture
The primary dental pulp cells (DPCs) used in this study were
isolated from the pulpal tissue of freshly extracted rodent incisor
teeth using enzymatic disaggregation [23]. All teeth were dis-
sected from male Wistar Hannover rats aged 25–30 days and
weighing 120–140 g. Post-extraction, the pulp tissue was extir-
pated from the teeth and minced aseptically into pieces of
approximately 1.0 mm2. The tissue was transferred into a 50 ml
Falcon™ tube (BD Biosciences, Oxford, UK) containing 4 ml Hank's
balanced salt solution (Sigma-Aldrich, Arklow, Ireland) (2.5 g/l
trypsin, 0.2 g/l ethylenediaminetetraacetic acid (EDTA) and 4Na)
prior to incubation at 37 1C at 95% relative humidity in a 5% CO2
atmosphere for 30 min (MCO-18AC incubator, Sanyo Electric,
Osaka, Japan). In order to improve dissociation, the cells were
constantly agitated during digestion (MACSmix tube rotator,
Miltenyi Biotec, Surrey, UK) prior to an equal volume of supple-
mented α-MEM (Biosera, East Sussex, UK) containing 1% penicil-
lin/streptomycin (Sigma-Aldrich) and 10% (v/v) foetal calf serum
(FCS) (Biosera) being added. In order to obtain a single cell
suspension, the digest was passed through a 70 mm cell sieve
(BD Biosciences) and the cells pelleted by centrifugation at
1200 rpm for 3 min, prior to re-suspension in 1 ml supplemented
α-MEM. Subsequently, the DPCs were expanded in culture to
passage 2 for use in all subsequent experiments. Unless otherwise
stated, all cultures were maintained in supplemented α-MEM at
95% relative humidity in a 5% CO2 atmosphere at 37 1C.HDACi
A 1 M solution of VPA (2-propylpentanoic acid sodium salt)
(Sigma-Aldrich) in phosphate buffered saline (PBS) (Sigma-
Aldrich) was diluted to a range of experimental concentrations
(30 mM–5 mM) with supplemented α-MEM. A 5 mM solution of
TSA (7-[4-(Dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-
7-oxo-2,4-heptadienamide) (Sigma-Aldrich) in dimethyl sulfoxide
(DMSO) was diluted in PBS prior to dilution to experimental
concentrations (3 nM–400 nM) in supplemented α-MEM.Evaluation of cell growth and viability
DPCs were seeded at a density of 1105 in 6-well plates
(Sarstedt, Wexford, Ireland) for 24 h to allow attachment and
initial proliferation. At 24 h (experimental day 0), the cells were
cultured in supplemented α-MEM for a further 1, 3 and 6 days.
VPA (0.25, 0.5, 1, 3 and 5 mM) and TSA (25, 50, 100, 200 and
400 nM) were added to the supplemented α-MEM, at day 0, for
the initial 24 h. The 1 day experimental cultures were harvested
after 24 h, while in the 3 and 6 day experiments the HDACi-
supplemented medium was replaced after 24 h with supplemen-
ted α-MEM for a further 2 and 5 days. The control samples
contained cells cultured in supplemented α-MEM without HDACi.
Cultures were detached with trypsin/EDTA (Sigma-Aldrich) and
stained with 0.4% trypan blue (Sigma-Aldrich) prior to cell
counting using a standard hemocytometer (Bright-Line™ Neu-
bauer Haemocytometer, Hausser Scientiﬁc, PA, USA). Three inde-
pendent experiments (n¼3) were performed in triplicate for each
HDACi concentration and time interval respectively, and DPC
number and viability recorded.Flow cytometry (FC)
FC detection (BD FACSCanto II, BD Biosciences) of annexin V (AV)
binding and propidium iodide (PI) staining (Annexin V-FITC Kit,
BD Bioscience) was performed to assess viability, necrosis and
secondary apoptosis. Cells were seeded at a density of 1105 on
6-well plates and cultured in supplemented α-MEM for 24 h, prior
to addition of VPA (1 and 5 mM) or TSA (100 and 400 nM) for
a further 24 h. The experimental time-point was chosen as
signiﬁcant early viability changes have been previously reported
with HDACi [4] and apoptosis at 24 h. Untreated cells in supple-
mented α-MEM served as a negative control. Cells in supplemen-
ted α-MEM with 6 μM camptothecin (Sigma-Aldrich) were
employed as a positive control to conﬁrm experimental apoptosis.
Cells were detached with trypsin/EDTA, washed twice with PBS
and suspended in a 1 AV binding buffer solution (BD
Bioscience) at a concentration of 1106 cells/ml. A 100 ml aliquot
of the cell suspension (1105) was transferred to a 5 ml poly-
styrene tube (BD Bioscience), prior to incubation at room tem-
perature with 5 ml FITC-AV and 5 ml PI for 15 min. Thereafter,
400 ml of 1 AV binding buffer solution was added to the tube
and the cells analyzed by FC within 1 h of harvesting. Excitation
was performed at 488 nm and the emission ﬁlters used for
AV-FITC and PI were 530/530 and 585/545, respectively. The data
were analyzed using FC software (FloJo, Tree Star, OR, USA) and
the PI staining intensity plotted against FITC intensity. Three
independent experiments (n¼3) were performed in triplicate
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control group.
High content analysis (HCA)
To determine the inﬂuence of VPA and TSA concentration on the
DPC cycle, proliferation and apoptotic marker expression at 24
and 48 h, HCA was performed. These early time-points were
based on a previous study [9]. The cells were seeded at a density
of 4103 in 96-well plates (Sigma-Aldrich) for 24 h, cultured
with supplemented α-MEM containing VPA (0.25, 0.5, 1, 3 and
5 mM) and TSA (25, 50, 100, 200 and 400 nM). Negative control
samples contained cells cultured in supplemented α-MEM with-
out HDACi. Positive control cultures had supplemented α-MEM
with HDACi, but no cells were seeded in those wells. Cells were
treated with VPA/TSA for 24 h prior to either ﬁxation (24 h
experimental samples) or further incubation for 24 h (48 h
experimental samples) in supplemented α-MEM prior to ﬁxation.
At the designated end-point, the medium was removed and cells
ﬁxed in 1% formaldehyde (Sigma-Aldrich) in PBS solution for
30 min. Subsequently, the cells were processed (Imagen Biotech,
Manchester, UK) by permeabilisation and stained with antibodies
against active caspase-3 (Cat# ab13847; Abcam, Cambridge, UK),
p53 (Cat# PN8400602; Thermo Fisher Scientiﬁc, Leicestershire, UK)
and p21 (Cat# PN8400602; Thermo Fisher Scientiﬁc). All antibodies
were diluted to 500 mg/ml digitonin/PBS solutions. Cross reactions
were visualized using two ﬂuorophore conjugated secondary anti-
bodies, namely goat anti-mouse 488 (Invitrogen, Paisley, UK) and
goat anti-rabbit 594 (Invitrogen) either in isolation or in combina-
tion. For cell cycle analysis, DNA was stained with Hoechst 33342 at
2.5 mg/ml (Invitrogen). The 96-well plates were analyzed on an
Arrayscan (Cellomics, Thermo Fisher Scientiﬁc) using a compart-
mental analysis algorithm. Three independent experiments (n¼3)
were performed in triplicate for each antibody investigated.Mineralization assay
Cells were seeded at a density of 6104 in 6-well plates and
cultured in supplemented α-MEM for 72 h until 60–70% conﬂuent.
At 72 h, the DPCs were cultured (day 0) in a mineralization
medium (supplemented α-MEM including 50 mg/ml ascorbic acid,
0.1 mM dexamethasone and 10 mM β-glycerophosphate) with the
addition of VPA (30, 60, 125, 250 and 500 mM) or TSA (3, 6, 12.5,
25 and 50 nM) for the initial 24 h of culture. The HDACi-
supplemented mineralization medium was removed after 24 h
prior to culture with an HDACi-free mineralization medium for a
further 13 days. This time-point was selected as rat DPCs in
mineralizing culture require 14 days to secrete quantitative
mineral that can be discriminatively measured by Alizarin red
staining. Control samples contained cells cultured in mineraliza-
tion medium without HDACi. The mineralization medium was
changed every 3 days. For analysis, cultures were washed 3 times
for 5 minutes in PBS and ﬁxed in 10% formaldehyde for 15 min,
washed with distilled water and ﬁnally stained with 1.37% (w/v)
alizarin red S (Millipore, Cork, Ireland) (pH 4.2) for 15 min at room
temperature. Excess stain was removed by washing with distilled
water; the residual stain was solubilised in 10% acetic acid
(Millipore) and the supernatant transferred to a transparent
96-well plate (Corning, Amsterdam, The Netherlands). Theintensity of stain was quantiﬁed spectrophotometrically at
405 nm [24] (Tecan Genios Spectrophotometer, Unitech, Dublin,
Ireland).
Mineralization was normalized by cell number. In a parallel
study, DPCs were cultured using an identical protocol to the
aforementioned mineralization assay for 14 days. After 14 days,
the cells were not ﬁxed, but detached with trypsin/EDTA and
stained with 0.4% trypan blue, prior to cell counting using a
standard hemocytometer. Mineral production per cell data for all
concentrations of VPA and TSA were subsequently calculated
based on quantiﬁcation of alizarin red S stain extracted from
each experimental well and corresponding cell counts. Three
independent experiments (n¼3) were performed in triplicate
for both the mineralization assay and cell counts, respectively.
RNA isolation and cDNA synthesis
Cells were seeded at a density of 6104 onto a 6-well culture
dish and cultured in 2 ml of supplemented α-MEM for 72 h until
60–70% conﬂuent. At 72 h (experimental day 0), the cells were
cultured for 24 h in supplemented mineralization medium con-
taining 125 μM VPA or 25 nM TSA, before incubation with an
HDACi-free mineralizing medium for a further 4 or 9 days
(experimental day 5 and 10). The 2 time-points selected for gene
expression analyses were planned to precede the later protein
expression experimentation. Control samples contained cells
cultured in mineralization medium without HDACi. Cultures were
detached with trypsin/EDTA, homogenized for 30 s using a T10
basic S2-Ultra-Turrax tissue disrupter (IKA, Staufen, Germany)
and RNA extracted using the RNeasy mini kit (Qiagen, West
Sussex, UK). RNA was isolated on the RNAeasy mini-column
assembly (Qiagen), prior to conversion to single-stranded cDNA
using the Omniscript kit (Qiagen) and oligo-dT primer (Ambion,
Applied Biosciences, Dublin, Ireland). Synthesized cDNA was
concentrated and puriﬁed by centrifugation with Microcon
YM-30 ﬁlters (Millipore) and cDNA concentrations determined
spectrophotometrically at 260 nm (Nanodrop 2000, Thermo
Fisher Scientiﬁc).
Semi-quantitative reverse transcriptase-polymerase
reaction (sq-RT-PCR)
Sq-RT-PCR analysis was performed for rat genes using speciﬁc
primers (Invitrogen). The primer sequences and the product sizes
are listed in Table 1 for each experimental target gene; dentine
matrix phosphoprotein-1 (DMP-1), dentine sialophosphoprotein
(DSPP), bone morphogenic protein-2 (BMP-2), bone morphogenic
protein-4 (BMP-4), nestin and the house keeping gene
glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Each PCR
included; 12.5 ml REDTaq ReadyMix™ PCR Reaction Mix (with
MgCl2) (Sigma-Aldrich, Arklow, Ireland), 0.5 ml Forward/Reverse
primer, 10 ml molecular grade water and 50 ng of template cDNA.
PCRs were performed using the GS-1G-Storm thermal cycler (G-
Storm, Surrey, UK) and subjected to a designated number (21–37) of
ampliﬁcation cycles, where a typical cycle was 95 1C for 20 s, 60 1C
for 20 s and 72 1C for 20 s. Following thermal-cycling, ampliﬁed
products were electrophoresed on a 1.5% agarose gel containing gel
red (Biotium, CA, USA), before visualization under ultra-violet
light with the AlphaImager-Mini system™ (Alphainnotech, Cell
Biosciences, CA, USA). Captured gel images were imported into
Table 1 – Primer sequences used for primary rat DPCs gene expression analyses.
Gene Primer sequence (5′-3′) Size bps Accession number
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (F)-CGATCCCGCTAACATCAAAT 391 NM_017008
(R)-GGATGCAGGGATGATGTTCT
Dentine matrix phosphoprotein-1 (DMP-1) (F)-TGCATTTTGAAGTGTCTCGC 248 NM_203493.3
(R)-CCTCCTGTCTTGGTGTGGTT
Dentine sialophosphoprotein (DSPP) (F)-TGCATTAAGTGTCTCGC 277 NM_012790.2
(R)-CCTCCTGTCTTGGTGTGGTT
Bone morphogenic protein-2 (BMP-2) (F)-TGAACACAGCTGGTCTCAGG 320 NM_012987.1
(R)-TGAACACAGCTGGTCTCAGG
Bone morphogenic protein-4 (BMP-4) (F)-ATGTGACACGGTGGGAAACT 323 NM_012827.2
(R)-AGTCCACGTAGAGCGAATGG
Nestin (F)-CATTTAGATGCTCCCCAGGA 285 NM_012987.1
(R)-AATCCCCATCTACCCCACTC
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metric analysis. Volume densities of ampliﬁed products were
normalized to GAPDH expression. Two independent experiments
(n¼2) were performed in replicate for both time intervals.Enzyme-linked immunosorbent assay (ELISA)
Cells were seeded at a density of 6104 in 6-well plates and
cultured in supplemented α-MEM for 72 h until 60–70% conﬂuent.
At 72 h, the DPCs were cultured (day 0) in a mineralization
medium with the addition of VPA (60, 125, 250 and 500 mM) or
TSA (6, 12.5, 25 and 50 nM) for the initial 24 h of culture.
The HDACi-supplemented mineralization medium was removed
after 24 h prior to culture with an HDACi-free mineralization
medium for further 5, 9 or 13 days. The quantiﬁcation of
mineralization associated proteins was investigated at 2 time-
intervals prior to the 14 day mineralization end point, to establish
a time-course analysis of OP and BMP-2 expression. Control
samples contained cells cultured in mineralization medium with-
out HDACi. The mineralization mediumwas changed every 3 days.
The OP and BMP-2 levels in the culture medium at experimental
day 6, 10 and 14 were analyzed with a commercial quantitative
sandwich ELISA technique (R&D Systems, Abingdon, UK) accord-
ing to the manufacturer's instructions and absorbance measured
at 450 nm. The protein concentration was normalized by cell
number at each time interval. At the end of the experimental
period (6, 10 or 14 days), the supernatant was removed for ELISA
and the residual attached DPCs were harvested with trypsin/EDTA
and stained with 0.4% trypan blue, prior to cell counting using a
standard hemocytometer. Protein production per cell was subse-
quently calculated based on colorimetric quantiﬁcation extracted
from each experimental well and corresponding cell counts. Three
independent experiments (n¼3) were performed in triplicate for
each experimental concentration and time interval.Statistical analyses
One-way analysis of variance (ANOVA) and Tukey's post-hoc tests
were used for all experiments to determine the inﬂuence of
HDACi concentration (po0.05) on the cells using SigmaStat 12.0.1
software (SPSS, IL, USA). Mean and standard deviation were used
for statistical analysis. To investigate the dose-dependent effectsof VPA and TSA, linear regression analyses were applied to the
mineralization per cell data.Results
Cell viability and proliferation in response to HDACi
Cell viability (Trypan blue exclusion) was not signiﬁcantly
reduced at any concentration of VPA (p40.107) or TSA
(p40.138) applied compared with the control at 1, 3 or 6 days.
However, growth was signiﬁcantly inhibited at 24 h by 3 mM/
5 mM VPA (p¼0.03/p¼0.004) and 100, 200, 400 nM TSA
(po0.021), at 3 days by 5 mM VPA (p¼0.008) and all concentra-
tions of TSA except 25 nM (p¼0.513). At 6 days, proliferation was
signiﬁcantly reduced with all experimental concentrations except
250 μM VPA (p¼0.974) and 25 nM TSA (p¼0.869), compared with
HDACi-free control cultures (Fig. 1A and B). Notably, while the cell
viability data assessed by FC (Fig. 1C–F), was not signiﬁcantly
affected at any VPA concentration (p¼0.605/p¼0.139); viability
was signiﬁcantly increased at 100/400 nM TSA (p¼0.006/
p¼0.032) (Fig. 1E and F).
Apoptosis was investigated by both FC and HCA of active
caspase-3. FC data demonstrated no signiﬁcant increase in
apoptosis following VPA (p¼0.741) or TSA (p¼0.577) exposure
at 24 h (Fig. 1E and F). HCA showed no signiﬁcant increase of
caspase-3 at 24 or 48 h for any concentration of VPA (p4..0.298)
or TSA (p4195) (Fig. 2A and B). HDACi-mediated growth inhibi-
tion in transformed cells has been attributed to induction of p21
[25] and p53 [26], however, no differences in transcription factor
p21 expression were demonstrated for VPA/TSA at 24 h (p40.766/
0.875) or 48 h (p40.763/0.773) (Fig. 2C and D). There were no
signiﬁcant changes in p53 expression at 24 h with VPA/TSA
(p40.658/p40.755) or 48 h with TSA (p40.406) (Fig. 2E and F),
while at 48 h, a signiﬁcant increase in p53 was identiﬁed at 3 mM
(p¼0.026) and 5 mM (p¼0.035) VPA (Fig. 2E, G and H).Cell differentiation
At 14 days, signiﬁcant increases in mineralization per cell were
evident for all VPA (po0.008) and TSA (po0.016) supplemented
concentrations with the exception of 3 nM TSA (p¼0.121) and
Fig. 1 – Growth and viability of primary DPCs cultured with HDACi. Experimental HDACi, VPA (A) and TSA (B) supplemented
cultures for 1, 3 and 6 days at a range of concentrations. Asterisk (n) for 0.5 mM VPA and 50 nM TSA concentrations, arrow (^) for
1 mM VPA and 100 nM TSA, symbol (4) for 3 mM VPA and 200 nM TSA and symbol (#) for 5 mM VPA and 400 nM TSA represent
statistically signiﬁcant differences (po0.05) between the experimental groups and the HDACi-free control. FC images for control
(no HDACi) (C) and 100 nM TSA (D). Viable cells were observed in the left lower quadrant, apoptotic cells in the right lower
quadrant and secondary necrotic cells in the right upper quadrant and charted as % total number of cells. Positive (6 μM
camptothecin), negative control (0 VPA/TSA) and selected concentrations of VPA (1 mM, 5 mM) (E) and TSA (100 nM, 400 nM) (F)
were investigated by FC at 24 h. Asterisk (n) represents statistically signiﬁcant differences (po0.05) between the experimental
groups (VPA and TSA) and HDACi-free control. Symbol (4) represents statistically signiﬁcant differences between all groups and
the positive control (po0.0001). All charted data are represented as mean7SEM.
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Fig. 2 – Expression of proliferation and apoptotic protein markers in primary DPCs cultured in the presence of a range of VPA and
TSA concentrations. Negative controls contained cell cultures not supplemented with HDACi, positive controls contained no cells
only media and HDACi. The number of cells expressing the marker-protein was recorded as a % of the total number of cells scanned
by HCA; active caspase-3 expression after addition of VPA (A) and TSA (B) at 24 and 48 h, p21 expression after VPA (C) and TSA (D) at
24 and 48 h and nuclear p53 after VPA (E) and TSA (F) at 24 and 48 h. Symbol (4) represents statistically signiﬁcant differences
(po0.05) between the experimental groups (VPA and TSA) and the HDACi-free negative control. Representative images for the
stained p53 HCA for control (G) and 5 mM VPA at 48 h (H); cell nuclei stained blue, p53 stained green and phosphorylated p53
stained red, which highlights a visible increase in expression of the transcription factor between the control and experimental
plates (original magniﬁcation 10 ).
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(Fig. 3A and B). Additionally, 250 μM VPA supplementation
demonstrated a signiﬁcant increase in mineralization compared
with all other VPA concentrations (po0.048), except 125 μM
(p¼0.124). VPA and TSA signiﬁcantly increased mineralization
per cell (po0.025) in a dose-dependent manner up to a plateau of
250 μM for VPA and 25 nM for TSA as demonstrated by positive
linear regression analyses (Fig. 3A and B).
As a dose-dependent HDACi-induced mineralization response
in DPCs was observed, further analysis of differentiation was
assessed by gene (Fig. 4A) and protein expression. VPA-treated
cultures signiﬁcantly increased their relative expression of DMP-1
(p¼0.011), BMP-2 (p¼0.041), BMP-4 (p¼0.03) and Nestin (p¼
0.037) at 5 days and DSPP (p¼0.03), BMP-4 (p¼0.002) at 10 dayscompared with HDACi-free equivalent cultures (Fig. 4Bi–v).
Signiﬁcant increases were demonstrated in the relative expres-
sions of BMP-4 (p¼0.049) at 5 days and DSPP (p¼0.012), BMP-2
(p¼0.017) at 10 days with TSA treated cells compared with the
control cultures. No differences in the relative expression levels of
DMP-1 and Nestin (Fig. 4B) were detected with TSA at 5 or 10
days. Increased OP protein levels by 10 days were evident in
response to exposure to 25/50 nM TSA (p¼0.049/p¼0.032) and to
all concentrations of VPA (po0.046) (Fig. 5Ai and Bi). At 10 days,
there was also a signiﬁcant increase in the expression of
BMP-2 protein levels for all VPA concentrations (po0.046), except
60 μM (p¼0.099) and all TSA concentrations (po0.039), except
6 nM (p¼0.061), compared with HDACi-free control cultures
(Fig. 5Aii and Bii). At 14 days, BMP-2 protein levels were
Fig. 4 – sq-RT-PCR demonstrating differential gene expression in primary DPCs for 5 and 10 day cultures with 125 μM VPA or 25 nM
TSA. Representative gel images (A) illustrating expression proﬁle of the housekeeping gene GAPDH and the mineralization/
dentinogenic-associated markers DMP-1, DSPP, BMP-2, BMP-4 and Nestin. Expression proﬁle of mineralization/dentinogenic-
associated markers DMP-1, DSPP, BMP-2, BMP-4 and Nestin relative to control. Volume densities of ampliﬁed products were
normalized to GAPDH gene expression. Averaged values for each group were calculated and charted as fold-increase of experimental
over control band density obtained for each transcript DMP-1 (Bi), DSPP (Bii), BMP-2 (Biii), BMP-4 (Biv) and Nestin (Bv). Statistically
signiﬁcant differences (po0.05) between the experimental and control are marked by asterisks (*).
Fig. 3 – Mineralization per cell analysis in primary DPCs cultured in an HDACi-supplemented mineralization medium. VPA (A)
concentrations of 30 μM, 60 μM, 125 μM, 250 μM and 500 μM and TSA (B) concentrations of 3 nM, 6 nM, 12.5 nM, 25 nM and 50 nM
supplemented in the mineralization medium for 24 h at the initiation of the experiment prior to culture for a further 13 days in
HDACi-free mineralization medium. Mineral production per cell data for VPA (A) and TSA (B) are based on quantiﬁcation of
Alizarin Red S stain extracted from each experimental well and corresponding cell counts. Statistically signiﬁcant differences
(po0.05) between the experimental and control is marked by an asterisk (*), while signiﬁcant differences between 250 μM VPA and
all other concentrations of VPA (except 125 μM) are marked by an arrow (^).
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Fig. 5 – OP and BMP-2 protein expression in primary DPCs cultured in an HDACi-supplemented mineralization medium. VPA
concentrations of 60 μM, 125 μM, 250 μM and 500 μM and TSA concentrations of 6 nM, 12.5 nM, 25 nM and 50 nM supplemented in
the mineralization medium for 24 h at the initiation of the experiment prior to the supernatant being collected at 6, 10 and 14 days
and analyzed by ELISA for OP (Ai and Aii) and BMP-2 expression (Bi and Bii) (all reported pg/mL). Statistically signiﬁcant
differences (po0.05) between the experimental and control are marked by asterisks (n).
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except 125 μM (p¼0.193) and at 25 nM and 50 nM TSA
(p¼0.0001, p¼0.02), while increased OP protein release was
evident at 250/500 μM VPA (p¼0.004/p¼0.009) and 25 nM TSA
(p¼0.040).Discussion
This study highlights the potential for HDACi in promoting reparative
events in the dental pulp and supports the original hypothesis that
the two HDACi investigated did not induce signiﬁcant anti-prolifera-
tive, apoptotic or necrotic effects, but did stimulate in vitro miner-
alization. Notably, the increased mineralization was dose-dependent,
which is consistent with previous studies utilizing osteoblast [27] and
dental-papilla derived cell lines [15,16]. However, this report supports
the different responses previously reported between primary and
transformed cells following exposure to HDACis [21]. Indeed, miner-
alization responses in DPCs were signiﬁcantly induced by concentra-
tions up to 10-fold lower than those previously reported as being
active in a transformed papilla-derived cell-line [15]. Nevertheless, the
HDACi-induced anti-proliferative effects were observed over similar
concentrations in both primary cells and the pulp cell-line, indicating
that the concentration ranges at which VPA/TSA stimulate mineral
deposition in primary cells were not associated with signiﬁcant
growth inhibition. HDACi-induced mineralization after 14 days
(≤3-fold increase compared with control) was evident in cultures
initially supplemented with VPA or TSA for 24 h, prior to culture for a
further 13 days in a HDACi-free mineralization medium (Fig. 3).Interestingly, extension of the initial HDACi supplemented culture
period (1–7 days) did not further enhance mineral deposition at 14
days (data not shown). Furthermore, up-regulation of the mineraliza-
tion and odontoblast-associated transcripts was also detected at 5 and
10 days, which are consistent with a previous report indicating that
an initial transient dose of HDACi sustains a pro-differentiation effect
[27], which is likely due to heritable epigenetic changes [27].
Concomitantly, analyses of mineralization-associated protein expres-
sion at 10 and 14 days further highlights VPA/TSA-induced differ-
entiation and corroborates previous reports of HDACi-induced
expression of these proteins in mineralizing cells [27,28].
The current study is the ﬁrst to use primary rat DPCs to investigate
the effect of HDACi on cell differentiation and behavior. A range of
experimental cell models have previously been used to analyze
in vitro mineralization including transformed cell-lines and primary
cells from rat, mouse, bovine, ovine and human origin [29]. Recent
pulpal research has utilized the developmentally derived cell-lines
MDPC-23 and OD-21 [30], while primary pulp cell models have
generally been of human and rat origin, with mouse, bovine and
ovine cells used less frequently [31]. Transformed cell-lines possess
certain advantages for use in the early stages of drug development as
they provide a relatively easily cultured, homogenous cell population
with no ethical barriers to use. However, caution should be exercised
in extrapolating results from these models as they have a limited
phenotypic expression and can exhibit different cellular behavior
compared with normal cells [18]. Human primary cells possess
properties more reﬂective of the in vivo situation, making them an
appropriate model for translational dental pulp research, however,
these cells are highly heterogenous, can be difﬁcult to source in
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genotype, donor age, gender, site and disease state of the tissue [32].
As a result, human studies can be limited by wide phenotypic
variation and exhibit a lack of homogeneity in responses, necessitat-
ing a signiﬁcant increase in the number of independent biological
samples required. A rat cell model addresses many of the short-
comings of human cell use, with gender, age, weight and pulpal
inﬂammatory state all readily controlled as well as providing a more
reliably accessible cell source. It is, however, acknowledged that the
mineralization processes in rat primary cells can be inﬂuenced by
donor sex or age [33] and the continuous growth pattern exhibited in
rat's incisor teeth throughout life, in contrast to the limited growth of
human teeth [34]. As species-related differences exist between rat
and human cells, care should be exercised in extrapolating in vitro
data to the clinic setting [29]. However, primary rat cells are reported
to provide a predictable and consistent model for primary cell
epigenetic research [5].
In addition to the induction of differentiation, other cellular
processes have been reported to be modulated by HDACi including
proliferation and these processes have been successfully targeted for
cancer treatment [1,5]. Notably, the mechanism of growth inhibition
in transformed cells is linked to cellular induction of the cyclin-
dependent-kinase inhibitor p21 [25], either p53-dependently or
independently [26]. Currently, there are relatively few primary cell
studies which have investigated HDACi-induced expression of p21/
p53 and in this study, growth inhibition was evident at the higher
concentrations of VPA/TSA applied with signiﬁcant increases in p53 in
response to VPA concomitantly detected. This relationship is some-
what expected as it has previously been reported that the HDACi-
concentrations required for anti-proliferative effects in cancer studies
are higher than those required for pro-mineralization and anti-
inﬂammatory responses [5,7]. Recently, the sensitivity of the cells to
p53-acetylation has been reported as being multi-factorial, being
inﬂuenced by cell-type, HDACi and the time-point investigated [35].
Speciﬁcally, it was identiﬁed that the VPA/TSA-mediated p53 effect
was evident at 12 h, but not at 24 h. In addition, induction of p53
expression required relatively high concentrations of VPA exposure
compared with TSA, and the authors attributed this to possible
variations in HDACi selectivity [35]. In the current study, the observed
increase in p53 acetylation was also time-dependent, as no altered
expression was evident at 24 h, only 48 h. The increase was only
evident for VPA, and not TSA, however, this is likely to be dose-
dependent and may well have been evident had we used exposure
concentrations above those used in this study. This analysis were not
however performed in the current investigation as this study aimed
to determine the p53-response in DPCs over a therapeutic range
induced by relatively low concentrations of HDACis. Therefore, a likely
explanation for VPA (but not TSA) eliciting p-53 expression is related
to the HDACi concentration used, in addition to the selectivity of VPA
compared with TSA.
However, no signiﬁcant increases in p21 levels were observed with
either HDACi applied. This may reﬂect variable kinetics of anti-
proliferative pathways, or that p21 is only stimulated in the pulp cell
line [15] and not in primary DPCs, or simply that p21 and p53
expression and activity are independent [35] To date, there has been
no pulpal research with regard to HDACi-induced p21/p53 expression,
however, it does appear, that at least for VPA, DPC growth inhibition
likely occurs via a p53-dependent pathway.
Notably, no observed change in apoptosis, caspase-3 expression or
viability occurred at any HDACi concentration supporting a resistanceto this toxicity in the primary cells used here, which contrasts with
the toxicity previously reported using transformed cell-lines [17,18]. It
has been proposed that HDACi-mediated resistance may be due to the
absence of ROS accumulation and caspase activation in primary cells,
which is evident in transformed cells [15,19,36]. The basis of this
selectivity may be related to the increased levels of intracellular
thioredoxin, which stimulate ROS scavengers and ribonucleotide
reductases in normal cells but not in transformed cells [17]. Addi-
tionally, it has been proposed that while primary cells possess the
capacity to repair HDACi-induced DNA double-strand breaks, trans-
formed cells are less able to do so and this may also contribute to the
differences in sensitivity observed [18,37]. Evidently, the HDACi-
mediated responses are different in DPCs and pulpal cell-lines and
this emphasizes the need to target further experimentation to
primary pulp cells as transformed cell-line data may have limited
clinical relevance.
No loss of vitality was observed at any HDACi concentration applied
and a signiﬁcant increase in the viability of DPCs was observed
following application of all concentrations of TSA compared with
control cultures (Fig. 1D and E). These data corroborate previous
reports using primary osteoblasts, which identiﬁed a transient
increase in cell viability in HDACi-treated cultures [4]. Interestingly,
a similar trend of VPA-induced increased viability was noted by FC
analysis, while not statistically signiﬁcant, the mean percentage
increase in viability between the TSA and VPA treated samples was
similar (2.7–5.3% viability increase for VPA; 4.6–6.4% for TSA) high-
lighting a common trend. A similar HDACi-induced increase in pulp
cell viability could potentially direct future research relating to the
ability of HDACi to protect pulp cells from toxic effects of dental
restorative materials, similar to work previously undertaken using
anti-oxidants [9,38,39].Conclusions
This study demonstrated that short-term application of two HDACi to
primary DPCs dose-dependently promotes epigenetically-related
mineralization and differentiation events at concentrations 10-fold
lower those previously described for transformed cells. In contrast to
transformed cells, mineralization is stimulated without a signiﬁcant
loss of cell viability and increase in apoptosis is suggestive of DPC
resistance to HDACi-mediated toxicity. Notably, for future translational
studies the promotion of tissue-repair processes was evident after a
single-dose of topical HDACi, thereby supporting the potential
beneﬁts of short duration, low concentration HDACi application for
vital pulp treatment.Acknowledgments
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CHAPTER 6 
 
PUBLICATION 5: ORIGINAL SCIENTIFIC MANUSCRIPT 
 
Duncan HF, Smith AJ, Fleming GJP, Partridge NC, Shimizu E, Moran GP, Cooper PR. (2016). 
The histone-deacetylase-inhibitor suberoylanilide hydroxamic acid promotes dental pulp 
repair mechanisms through modulation of matrix metalloproteinase-13 activity. J Cell 
Physiol 231:798-816. 
 
It has been previously demonstrated that HDACi promoted primary DPC mineralisation at 
significantly lower concentrations than transformed cells, without an associated loss of cell 
viability or an increase in cell apoptosis (Chapter 5). However, elucidation of the mechanisms 
driving the regenerative events remained unresolved. In this study, it was hypothesised that 
the mechanism modulating the regenerative properties of one clinically-approved HDACi 
(SAHA) related to transcriptional changes which affected selected mineralisation-associated 
pathways. The initial element of this study aimed to identify the regulators by which SAHA 
promoted regenerative processes in primary DPCs using a combination of gene expression 
microarray, pathway analysis, and molecular validation. Thereafter, pharmacological 
inhibition of an HDACi-induced novel transcript was investigated using mineralisation, RT-
PCR, protein expression and cell migration assays to confirm its role in SAHA-modulated DPC 
repair. 
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CHAPTER 7 
 
PUBLICATION 6: REVIEW 
 
Smith AJ, Duncan HF, Diogenes A, Simon S, Cooper PR. (2016). Exploiting the bioactive 
properties of the dentin-pulp complex in regenerative endodontics. J Endod 42:47-56.  
 
Dentine is increasingly regarded as a reservoir of bioactive molecules which can be released 
into the pulpal environment by restorative procedures, carious processes or dental materials 
and thereafter, augment reparative/regenerative events in the dentine-pulp complex. The 
action of released DMCs works in synchrony with the bioactive molecules generated locally 
by DPCs to promote repair processes. The aim of this study was to review the literature 
focusing specifically on the role of bioactive molecules located in the dentine-pulp complex 
and their potential contribution to pulpal reparative events following injury and as a part of 
regenerative endodontic therapeutic strategies. 
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Introduction: The development of regenerative end-
odontic therapies offers exciting opportunities for future
improvements in treatment outcomes. Methods: Ad-
vances in our understanding of regenerative events at
the molecular and cellular levels are helping to underpin
development of these therapies, although the various
strategies differ in the translational challenges they
pose. The identification of a variety of bioactive mole-
cules, including growth factors, cytokines, chemokines,
and matrix molecules, sequestered within dentin and
dental pulp provides the opportunity to present key
signaling molecules promoting reparative and regenera-
tive events after injury. Results and Conclusions: The
protection of the biological activity of these molecules
by mineral in dentin before their release allows a
continuing supply of these molecules, while avoiding
the short half-life and the non-human origin of exoge-
nous molecules. The ready release of these bioactive
molecules by the various tissue preparation agents, me-
dicaments, and materials commonly used in endodon-
tics highlights the opportunities for translational
regenerative strategies exploiting these molecules
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JOE — Volume 42, Number 1, January 2016Endodontics is constantly evolving through improvements in our understanding of thebasic sciences underpinning disease and its treatment, advances in materials and
other technological innovations, together with the accumulation and sharing of clinical
experience gained by practitioners. The combination of all of these various factors pro-
vides the greatest opportunities for improved clinical outcomes. Biologically based ther-
apies have long been important in endodontics and offer significant promise for future
developments. Historically, pulp capping and other approaches to pulpal wound heal-
ing can be traced back to at least the 18th century (1). More recently, however, ad-
vances in biology have allowed the basis of these approaches to be better
understood and for novel, more targeted approaches to be pursued.
The term regenerative endodontics can be defined according to one’s own
perception as to what it encompasses. Perhaps in its least specific definition, it encom-
passes many of the different biologically based therapies aimed at stimulating pulpal
wound healing. The American Association of Endodontists (AAE) defines regenerative
endodontics as ‘‘biologically based procedures designed to replace damaged struc-
tures, including dentin and root structures, as well as cells of the pulp dentin complex’’
(2). This definition clearly states that the aim of these procedures is the replacement of
lost cells and root structure without making the claim that this replacement is a com-
plete recapitulation of the once lost tissue. However, a much narrower definition could
be used that implies that these procedures must induce the regeneration of new tissue
resembling the native pulp-dentin complex at the histologic level with the expected
physiological functions; however, this seems an unlikely outcome of current regener-
ative endodontic approaches (3). Reports of endodontic procedures that use an intra-
canal antibiotic paste containing metronidazole and ciprofloxacin (double antibiotic
paste) (4) or a triple antibiotic paste (5) combined with early investigations of the
role of the blood clot in pulpal healing (6) have helped to develop clinical regenerative
endodontics in recent years. A variety of chair-side procedures involving creation of a
blood clot in a diseased pulp have now been reported and are often described as revas-
cularization procedures (7). These reports have all contributed to a call for action to
develop regenerative endodontic therapies for clinical use (2) and initiatives from the
AAE to collate experience and support development of regenerative endodontics in clin-
ical practice. There are now several examples of variations of the original clinical revas-
cularization procedures that include the use of other scaffolds such as platelet-rich
plasma (8), platelet-rich fibrin (9), and gel foam (10), as well as the application of
exogenous growth factors such as fibroblast growth factor 2 (FGF-2) (10). These var-
iations, among other developments, highlight the rapid evolution of the field of regen-
erative endodontics and the translational nature of its propelling research. Although
there is no consensus definition of regenerative endodontics, the exciting future exploi-
tation of this area may be best served by the adoption of a less strict definition for regen-
erative endodontics and the avoidance of semantic debates. In this way, clinical practice
can keep progressing with the application of regenerative procedures that focus on
meaningful patient-centered outcomes such as resolution of the disease and tooth sur-
vival. However, we recognize complete regeneration of a pulp-dentin complex that re-
sembles the native lost tissue remains the ultimate goal, and that it is the driving force of
considerable research efforts that are moving the field of regenerative endodontics into
future more sophisticated therapy modalities.
Indeed, the biological focus of the exciting research in regenerative endodontics
has greatly advanced our understanding of this area. In this review, we focus specificallyDentin Bioactivity and Regenerative Endodontics 47
Regenerative Endodontics
on the involvement of bioactive molecules found in dentin-pulp, their
potential contributions to reparative/regenerative events, and their po-
tential clinical exploitation. Although targeting bioactive molecules
within dentin-pulp represents only one facet of regenerative endodon-
tics, it may potentially allow rapid progress to be achieved within this
area in the short-term with only subtle changes to existing clinical
practices.Bioactive Properties of Dentin and Pulp
Traditionally, dentin has been regarded as a relatively inert miner-
alized connective tissue that shows minimal remodeling after formation
and in the absence of disease. In contrast, pulp is considered to
resemble a classic soft connective tissue in terms of displaying turnover
and remodeling, although its more gelatinous consistency contrasts
with the fibrous nature of many other connective tissues. Although these
perceptions of dentin and pulp have long been clinically prevalent, it is
important to recognize that dentin has been known to show bioactive
properties for more than 4 decades. Demineralized dentin matrix
was demonstrated to induce pulpal repair (11) and apical closure
(12) in primates, and this inherent pro-mineralizing effect was report-
edly due to bone morphogenetic protein (BMP) activity (13–16).
Subsequently, the soluble pool of non-collagenous proteins in dentin,
which is released during demineralization of the tissue, was reported
to induce both reparative (17) and reactionary dentinogenesis
(18, 19). Furthermore, the actions of transforming growth factor-b
(TGF-b) and other BMP family members on induction of odontoblast
terminal differentiation in tooth development could be replicated by
preparations of soluble dentin non-collagenous proteins (20). Thus,
the perceived inertness of dentin reflects the immobilization and
sequestration of these bioactive molecules within the matrix. However,
their subsequent dissolution such as during caries provides a local
release of their bioactivity.
Earlier studies focused on minimally purified dental tissue prep-
arations, and where characterization of the preparations was under-
taken, the analytical techniques were constrained in their ability toTABLE 1. Key Growth Factors and Morphogens Present in Dentin Known to Play I
Key growth factors in dentin matrix
TGF-b1 (23, 24) Involved in prima
tertiary dentin
TGF-b2 (23) Its expression is u
phenotype (27
TGF-b3 Promotes odonto
BMP-2 (30) Promotes odonto
the induction o
BMP-4 (30) Increases odonto
BMP-7 (34) Promotes minera
Insulin growth factor-1 (37, 38) Promotes prolifer
phenotype (39
Hepatocyte growth factor (41) Promotes migrati
VEGF (24, 43) Potent angiogen
formation in to
Adrenomedullin (48, 49) Promotes odonto
FGF-2 (24, 43) Promotes stem ce
Platelet-derived growth factor (23) Promotes angiog
odontoblastic
factors (53)
Epidermal growth factor (43) Enhances neurog
Placenta growth factor (43) Promotes angiog
Brian-derived neurotrophic factor (38) Promotes neuron
Glial cell line–derived neurotrophic factor (38) Promotes nerve r
Increased in ex
Growth/differentiation factor 15 (38) Promotes axonal
in neuronal ma
48 Smith et al.resolve individual bioactive molecules. However, advances in under-
standing of the nature of these various bioactive molecules and the
techniques used for their characterization have since allowed a
diverse group of molecules to be identified, many of which were
recently reviewed (21). This diverse group of molecules encom-
passes growth factors, chemokines, cytokines, extracellular matrix
molecules, and bioactive peptides, reflecting the complexity of the
cellular signaling events capable of being induced. The subsequent
discussion of these bioactive molecules and their potential involve-
ment in dentin-pulp regeneration will focus on the signaling involved
in the cascade of biological events associated with regeneration
rather than simply cataloguing the molecules present. Although
considerable research has investigated the biological actions of indi-
vidual molecules in dentin-pulp regeneration, the microenvironment
at sites of tissue injury will reflect the local dissolution of a multitude
of bioactive molecules; thus, it is important to note that the summa-
tion and indeed synergistic actions of these molecules may differ
significantly from those when present individually (22). Although a
diverse range of bioactive molecules are also found within the dental
pulp, their long-term bioavailability may be constrained by more
rapid turnover of the pulpal extracellular matrix and the fact that
this source may be unavailable in cases of pulpal necrosis. Thus,
dentin can be considered a reservoir of growth factors and other
bioactive molecules with important roles in repair and regeneration
(Table 1).
The inertness of dentin reflects the immobilization and sequestra-
tion or ‘‘fossilization’’ of the bioactive molecules within the matrix. In
health, these molecules will largely remain in their ‘‘fossilized’’ state,
and it is only when injury and disease occur that matrix dissolution
can be observed, leading to local release of these bioactive molecules.
This is perhaps an oversimplification because the mechanism of immo-
bilization/association of different bioactive molecules within the dentin
matrix varies. In some cases, these molecules are associated with the
dentinal mineral phase by a relatively nonspecific, perhaps ionic bind-
ing. However, for other molecules, the binding may be more specific in
nature (eg, the specific interaction of TGF-b1, although not othermportant Roles in Regeneration and Repair
Regenerative function
ry odontoblastic differentiation (25, 26) and in promoting
ogenesis (20)
pregulated on differentiation of DPSCs into a mineralizing
)
blastic differentiation (28, 29)
blastic differentiation in both in vitro and in vivomodels (31) and
f DSPP and increases alkaline phosphatase activity (32)
blastic differentiation (33)
lizing phenotype in DPSCs (35, 36)
ation and differentiation of DPSCs and SCAP into a mineralizing
, 40)
on, proliferation, and survival of MSCs (42)
ic factor (44–46) that has been shown to promote blood vessel
oth slices implanted subcutaneously in SCID mice (47)
blastic differentiation through activation of p38 (22)
ll homing (chemotaxis), stemness, and angiogenesis (44)
enesis (50), chemotaxis of MSCs (51), modulates the process of
differentiation (52), acting synergistically with other growth
enic differentiation of DPSCs (54) and SCAP (55)
enesis (44) and osteogenic differentiation of MSCs (56)
al growth and axonal targeting (57)
egeneration in vivo (58) and pulp cell survival/proliferation (59).
pression during odontogenic differentiation (60).
regeneration and function after injury and plays important role
intenance (61)
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isoforms, with decorin/biglycan in dentin) (62). Thus, dissolution of
different bioactive molecules from dentin may occur over a range of
conditions that permit modulation of the release of these molecules.
Our understanding of the different tissue pools of various molecules
in dentin-pulp and their relative solubility is still very limited; however,
a better understanding could provide a powerful means to enable
release of these molecules to stimulate natural repair processes.
Biological Events Associated with Regeneration
Repair and regeneration of dentin-pulp comprise a cascade of
cellular events with matrigenic, angiogenic, and neurogenic outcomes,
reflecting the various processes associated with generation, homeosta-
sis, and function of these tissues. In natural pulpal wound healing, all of
these processes are initiated and controlled by a variety of signaling
molecules derived from the matrices of dentin-pulp as well as defense,
inflammatory, and immune cells associated with disease and its pro-
gression. To understand the potential scope of dentin-pulp derived
bioactive molecules in repair/regeneration, it is helpful to consider
the cascade of cellular processes and events taking place (Fig. 1).
The physiological embryonic development of the dentin-pulp
complex is coordinated by an exquisite blueprint of processes under
tight temporospatial control (26). Conversely, the postnatal repair
and regeneration of these tissues show much less degree of regulation.
In part, the less controlled environment of repair and regeneration is a
consequence of the exposure and release of a variety of bioactive mol-
ecules with potent cellular signaling properties from dentin-pulp in
addition to the interplay with the inflammatory process (63). The
more limited temporospatial and dosage regulation of signaling mole-
cules, as compared with physiological tooth development, emphasizes
the pathologic nature of events occurring during repair/regeneration.
This perhaps helps to explain why clinical regeneration of a truly
physiological-like pulp tissue is a daunting goal. The complexity of
the cellular signaling environment is further exacerbated by the dy-
namics of the disease process on the release and exposure of bioactive
molecules in dentin-pulp and their functional modifications through
partial degradation by the acidic and enzymatic activities associated
with disease progression (64, 65). Furthermore, surgical
intervention by the clinician with endodontic irrigants, disinfectants,
medicaments, and other agents will likely also modulate the signaling
environment. We will describe how this complex and variable
signaling environment may influence cellular events after injury and
offers exciting opportunities for development of new therapeutic
approaches that exploit the bioactive molecules in dentin-pulp.Figure 1. Schematic of the cascade of biological steps associated with healing eve
JOE — Volume 42, Number 1, January 2016Although correlation of specific bioactive molecules with the different
signaling steps associated with repair/regeneration is a laudable goal,
some of these steps may involve networks of molecules, and also,
more than 1 molecule may be able to duplicate the same action for
some steps, reflecting either biological redundancy or other nuances
of signaling.Pulp Cell Niche and Stem Cell Behavior
Stem cells reside within niches, which provide a microenviron-
ment responsible for maintaining the cells in their stem-like, undiffer-
entiated state. This niche is determined by a complex interplay between
the stem cells themselves, surrounding cells of various lineages, extra-
cellular matrix, and soluble molecules including growth factors. These
niches are generally regarded as providing relatively stable microenvi-
ronments, which likely only undergo significant disruption during
disease and tissue remodeling. Although the concept of the niche is
well-established, our understanding of its nature and behavioral influ-
ences on stem cells is still limited. These niches are often described by
various markers known to be expressed at these sites, although the
functional importance of many of these markers remains unclear. How-
ever, Notch signaling has been proposed to be important in controlling
stem cell fate in the dental pulp after tooth injury (66). In the dental
pulp, a perivascular stem cell niche has been reported (67, 68),
which perhaps reflects the transient movement of vasculature-derived
stem cells to the pulp. The prominent compartmentalization of stem
cells on blood vessels within the apical papilla (69) and inflamed peri-
apical tissues (70, 71) also indicates that perivascular stem cells
participate in current regenerative procedures that have been shown
to recruit cells from the apical region in both immature (72) and
mature teeth (71).
Many of the bioactive molecules present in dentin-pulp have the
potential to influence stem cell niches, although our understanding of
these interactions is limited. Growth of pulp cells on a layer of isolated
pulp extracellular matrix was shown to decrease their proliferation rate
and favor expression of a stem cell–like phenotype (73). Furthermore,
when these cells were grown in mineralization-inducing conditions, the
pulp matrix allowed increased mineralization. Indeed, it has been
demonstrated that the ‘‘stemness’’ of mesenchymal stem cells (MSCs)
can be prolonged in culture when these cells are cultured on an extra-
cellular matrix that mimics their native niche (74). Collectively, these
studies demonstrate that the niche with its rich array of attachment
and bioactive molecules has the ability to maintain stem cells at theirnts during dentin-pulp regeneration.
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maximum differentiation potential. However, there is still much to learn
of the cell-matrix interactions controlling pulp stem cell behavior.Pulp Stem/Progenitor Cell Recruitment
Recruitment of stem/progenitor cells from their perivascular or
other niches is a critical step in regeneration and guided tissue
repair after injury. Release of chemotactic molecules, such as dentin
or pulp matrix-derived molecules, at sites of tissue injury may be
important to the recruitment process (Fig. 2). Perivascular niches
for stem cells are attractive sources for recruitment after carious
injury because of the close proximity of much of the pulp vasculature
to the odontoblast layer (75, 76). Both dentin and pulp matrices
have been reported to contain molecules with chemotactic
properties (53, 65, 77), and although some of this activity may be
ascribed to growth factors with known cell homing properties
(53), other molecules are also likely to be involved. For example,
complement activation and generation of C5a has been reported to
be one of the molecules associated with lipopolysaccharide-
induced pulp progenitor cell recruitment (77).
The target cell specificity of these chemotactic molecules in dentin
and pulp is still not well-understood. Dentin matrix proteins can induce
recruitment of cells involved in the inflammatory and immune re-
sponses of the pulp after injury (78) as well as pulp cells (65), and
in the latter report, preferential attraction of cells expressing a range
of stem cell markers was observed. Matrix-resident chemotactic mole-
cules provide attractive candidate mediators for stem/progenitor cell
recruitment because their release during carious tissue dissolution
(18, 79) and irrigants like EDTA (24, 80, 81) used during
endodontic treatment will likely lead to chemotactic gradients
providing cues for the spatial localization of stem cells along dentinal
walls in regenerative endodontic procedures (Fig. 2).Figure 2. Schematic illustrating the potential actions of irrigants and medicaments i
their influences on regenerative events including chemotaxis, odontoblast-like cell
50 Smith et al.Pulp Stem/Progenitor Cell Expansion
Little consensus exists as to how many stem/progenitor cells
exist within the dental pulp or even how many are required during
repair and regeneration after tissue injury. However, it may be ex-
pected that the numbers of resident stem cells are relatively small,
and some in situ or ex vivo expansion of their numbers may be
required during repair and regeneration. Interestingly, the apical
papilla (82) and the inflamed periapical tissues (70) appear to be
enriched sources of undifferentiated stem cells that may play an
important role in regenerative endodontics, particularly in immature
teeth with open apices. Many of the bioactive molecules identified
within dentin and pulp show proliferative effects on a variety of
cell types including stem cells (73). Some of these activities may
be ascribed to the various growth factors within dentin-pulp (15),
although other molecules resident in these matrices will likely also
contribute to such activities. Although it is valuable to try and cata-
logue all of the individual bioactive molecules demonstrating in vitro
proliferative activities on various pulp cell populations in dentin-
pulp, caution must be taken in extrapolation of such data to the
in vivo situation. After injury to the pulp, there will be a complex
cascade of cellular events taking place involving an intricate interplay
of many bioactive molecules, including inflammatory mediators, with
cell signaling properties (83). Anticipation of the outcomes of these
interplays of molecules can be very difficult because it is not only the
summation of the individual proliferative activities of these molecules
that drives the outcomes but also the influence of various autocrine
and paracrine regulatory factors in the in vivo tissue environment.
Attempts to investigate proliferative events in vivo during
odontoblast-like cell differentiation after tooth injury have clearly
demonstrated the active nature of these events (84). However, there
is still much to learn of the details of the signaling of these prolifer-
ative events and their regulation.n the release and/or exposure of bioactive molecules sequestered in dentin and
differentiation, mineralization, angiogenesis, and neurogenesis.
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Localized odontoblast cell death often follows moderate to severe
dental trauma or carious injuries. Recruitment and differentiation of a
new generation of odontoblast-like cells may subsequently ensue, al-
lowing reparative dentinogenesis to occur, such as is seen in situations
of mineralized bridge formation after pulp-capping procedures (17).
Differentiation of odontoblast-like cells during reparative dentino-
genesis shows a number of parallels with the terminal differentiation of
primary odontoblasts during tooth development (25). However, it must
be recognized that differentiation of a new generation of odontoblast-
like cells is a pathologic rather than physiological event, and the tightly
regulated temporospatial control of odontoblast differentiation seen
during tooth development is lacking. As a consequence, there may be
considerable heterogeneity in the phenotypes of odontoblast-like cells
and the matrices they secrete. At the morphologic level, this may be seen
as variations in the tubular nature of dentin (85). Also, there appears to
be differences in mineral composition of that formed by different MSC
populations such as dental pulp stem cells (DPSCs) and stem cells of the
apical papilla (SCAP), suggesting also heterogeneity that is based on the
cell type involved in the differentiation process (86).
There is a dearth of knowledge relating to the molecular markers
identifying ‘‘true’’ odontoblast-like cells from other forms of mineral-
izing cells such as osteoblasts. Nevertheless, it is important to remember
that odontoblast-like cells do not represent a single, well-defined
phenotype, and this has crucial implications for their robust identifica-
tion. Although primary odontoblasts express a profile of molecular
markers, including nestin, dentin sialophosphoprotein (DSPP), dentin
matrix protein 1 (DMP-1), and matrix extracellular phosphoglycopro-
tein among other markers, such a profile is not unique to odontoblasts,
and relatively simple molecular characterization is not necessarily a
robust means of identifying the odontoblast phenotype. The addition
of other identification criteria such as cellular morphology and matrix
morphology, especially regularity of tubular structure, can increase
confidence, although the application of these additional criteria is not
necessarily easy. For example, the morphology of an odontoblast varies
through its secretory life cycle (87, 88), and the tubular density of
dentin will vary at different points of its thickness because of
odontoblast crowding as dentinogenesis proceeds in a pulpal
direction. Therefore, it is easy to see that the widespread
identification of odontoblast-cell differentiation during dentin-pulp
repair/regeneration in many different published studies in this fieldFigure 3. Illustration of the steps associated with clinical management of a tooth
molecules leading to regeneration.
JOE — Volume 42, Number 1, January 2016may not be quite as robust as previously thought. In the majority of these
studies, there is little doubt that differentiation of a mineralized cell
phenotype occurred, but whether these cells truly share the same
phenotype as their physiological counterparts, the primary odonto-
blasts, remains unresolved. In functional terms, these various
odontoblast-like cells and the matrices they secrete likely provide satis-
factory outcomes for clinical procedures aimed at restoring the func-
tional integrity of injured dental tissues. However, they cannot be
considered to provide true regeneration of physiological-like morphol-
ogies for these tissues, and our limited understanding of the factors
driving their differentiation means their generation can be somewhat
serendipitous.
To try and identify the key morphogenic molecular signals for
odontoblast-like cell differentiation, it is useful to look to those events
occurring during physiological tooth development. During the late bell
stage, inner enamel epithelium-derived growth factor signals, immobi-
lized on the dental basement membrane, are presented to the periph-
eral cells of the dental papilla, leading to their terminal differentiation
to odontoblasts (89). TGF-b superfamily members appear to be
responsible for signaling odontoblast terminal differentiation physio-
logically and experimentally, because only immobilized TGF-b1 and
TGF-b3 or a combination of FGF-1 and TGF-b1 could stimulate the dif-
ferentiation of functional odontoblasts over extended areas of the dental
papilla and allow for maintenance of gradients of differentiation (20,
90, 91). The ability of preparations of soluble dentin matrix proteins
to mimic the effects of these growth factors on experimental
embryonic odontoblast differentiation (20) also concurs with the ef-
fects of such dentin matrix preparations on odontoblast-like cell differ-
entiation and reparative dentinogenesis in pulp-capping applications
(17). The effects of dentin matrix components on the induction of den-
tinogenesis in pulp-capping situations have long been recognized (11,
17, 92) and may be due to the presence of a range of growth factors in
dentin matrix preparations, including members of the TGF-b
superfamily (14, 23, 37, 41, 43, 93) (Fig. 3). This is supported by re-
ports of tissue-isolated and recombinant growth factors paralleling the
actions of dentin matrix preparations (14, 15, 94). However, other
components of dentin and pulp may also display morphogenic
activity including extracellular matrix molecules such as DMP-1 (95)
and BMPs (16, 20). Nonetheless, robust characterization approaches
for the phenotype(s) of odontoblast-like cells and experimental func-
tional deletion strategies are required to resolve which componentswith irreversible pulpitis and the potential release of growth factors and other
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of dentin matrix preparations are essential for signaling odontoblast-
like cell differentiation and to what extent the resultant cells resemble
physiological primary odontoblasts.
Dentinogenic Cell Secretion and Its Control
Focus is generally centered on cell differentiation during repair/
regeneration in dentin-pulp, but upregulation and control of subse-
quent secretion by the differentiated cell are also important. Control
of dentin secretion occurs physiologically, with downregulation after
completion of primary dentinogenesis and upregulation again occur-
ring during episodes of tertiary dentinogenesis. In the absence of regu-
lation of odontoblast secretion, pulp canal obliteration can ensue, with
significant implications for both tooth vitality and endodontic treatment
(96). Members of the TGF-b superfamily are capable of upregulating
odontoblast matrix secretion under both physiological conditions
(20) and in an in vitro repair/regeneration model (93). The target
for this cell signaling appears to be activation of the mitogen-
activated protein kinase pathway through p38 phosphorylation (22).
Identification of this molecular switch for odontoblast secretory activity
offers exciting opportunities to clinically modulate such activity through
combinations of local targeting with growth factor stimulation or phar-
macologic manipulation leading to a more controlled rate of mineral
deposition.
Angiogenesis and Neurogenesis
Both the rich vasculature and a well-developed neural network in
the pulp are important for its regeneration and function. After injury or
chemical dentin conditioning, various proangiogenic growth factors
sequestered in dentin (43) may be mobilized. Their proangiogenic ac-
tivities (97, 98) may well contribute to local increases in vasculature to
support reparative/regenerative events (Figs. 1 and 2). It is well-
accepted that angiogenesis is crucial for regenerative procedures
because despite being well-equipped to thrive in hypoxic environments
(55), stem cells require adequate nutrient supply and gaseous ex-
change, particularly when in high metabolically demand secretory
phases post-differentiation (99). Histologic evidence from both animal
models (100–102) and clinical cases of revascularization procedures
(103, 104) demonstrates that a good blood supply appears to be
present after these procedures. This could be due to the angiogenic
factors present on the dentinal matrix and released after the use of
EDTA in revascularization procedures (24). In addition, MSCs when
found in the hypoxic root canal system can release enhanced concen-
trations of angiogenic factors such as vascular endothelial growth factor
(VEGF) (45, 105). Therefore, current procedures are known to
promote robust angiogenesis and are likely driven by locally released
growth factors from dentin and recruited stem cells.
The human dental pulp is richly innervated by primarily nocicep-
tors, including neurons expressing potent neuropeptides such as calci-
tonin gene-related peptide, substance P, and neuropeptide Y (106). On
pulpal injury, there is significant neuronal sprouting to the area of injury
and repair (107). This enriched innervation is suggestive of a modula-
tory effect of neurons on dentin-pulp repair. Indeed, re-innervation
coincided with pulpal healing and tertiary dentin formation in a model
of pulpal repair after replantation of teeth (108), and denervation via
nerve transection or pharmacologic ablation results in aberrant dentin
formation (109, 110).
Although our understanding of neurogenic events after injury and
regenerative endodontic procedures is more limited, the variety of neu-
ropeptides and neurotrophic molecules expressed by odontoblasts and
surrounding fibroblasts appear to play a role in the recruitment of
nearby free nerve terminals to the area of tissue repair/regeneration52 Smith et al.(106, 111–114). In addition to resident pulpal cells, recruited MSCs
such as SCAP have been shown to mediate axonal sprouting and
targeting through a brain-derived growth factor mechanism (57). Inter-
estingly, in a dog model of regenerative endodontics, a subpopulation of
DPSCs with increased expression of brain-derived neurotrophic factor
was transplanted into empty root canals, resulting in the formation of an
innervated pulp-like tissue (115, 116). Therefore, adequate
innervation should be a goal of regenerative endodontics because
neurons mediate protective nociception and the modulation of
homeostasis processes such as inflammatory responses and
odontoblastic function.Infection, Inﬂammation, and Regeneration
As the local environment of the tooth changes and becomes more
anaerobic, the carious bacterial biofilm composition becomes more
complex as it drives through the enamel, dentin, and pulp (117).
The dentin-pulp complex aims to defend itself from the bacterial
onslaught, and in the early stages of dental tissue infection, the odonto-
blasts detect and respond to the microbial presence (118, 119). As the
infection progresses, cells more centrally located within the pulp,
including resident immune cells, pulpal fibroblasts, vascular
endothelial cells, and even stem cells, are also able to mount a
response aimed at containing the infection (120–122). A variety of
microbial sensors have been described as being present on these cell
types, and the best characterized are the Toll-like receptor family that
can detect microbial components ranging from their nucleic acids to
cell wall constituents (122). After detection of the infection by host cells,
cytokines such as interleukin (IL)-1a, IL-1b, tumor necrosis factor
alpha, IL-4, IL-6, IL-8, and IL-10 are secreted, and depending on levels
and temporality, they can lead to several cellular and tissue outcomes
(123, 124). At the early stages and/or at relatively low levels of
infection, the inflammatory response may be sufficient to not only
contain and remove the infection via the local release of
antimicrobial peptides and reactive oxygen species (ROS) but may
also stimulate dental tissue repair responses. Indeed, there is now
significant evidence to indicate that cytokines and other
proinflammatory mediators such as ROS can directly stimulate dental
tissue repair responses. However, if the infection increases, there will
be an elevation of the inflammatory response mediated by the
cytokine signaling network generated from the local cells and from
the demineralized dentin that also releases signaling molecules into
the milieu (83). Combined, this will lead to increased recruitment of
a range of inflammatory cells, including neutrophils, macrophages, T
cells, B cells, and plasma cells, which aim to use their intracellular
and extracellular armamentarium to contain and kill the invading bac-
teria (125–128). This localized protective response to tissue infection
and injury aims to prepare the tissue for eventual repair, and ideally the
inflammatory reaction should be short-lived. Indeed, if it is excessive or
prolonged, it will likely result in tissue damage because of either the
direct toxic effect of the bacteria or the exuberant host response that
results in collateral tissue damage in its attempts to combat the infection.
Central to both the inflammatory and healing responses is the role
of the vasculature and the induction of angiogenesis. As has previously
been described, angiogenic events can be triggered by the release of
potent signalingmolecules from the demineralized dentin. Interestingly,
many cytokines classically regarded as being fundamental to the inflam-
matory response, such as IL-1, IL-6, and IL-8, are also proangiogenic
(129–131). This pleiotropism is potentially not surprising because of
the need for a robust vascular response to enable the delivery of the
immune cells to the dental tissue and the removal of unwanted
material such as toxic molecules and metabolites. Indeed, the first 3JOE— Volume 42, Number 1, January 2016
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of the 4 cardinal signs of inflammation—redness, warmth, swelling,
and pain—are attributable to the vascular response. To empower the
immune and repair responses within the vasculature, adhesion of
immune cells and platelets is activated, as is coagulation, thrombosis,
and vascular permeability. These processes enable delivery of
inflammatory cells to the diseased tissue while isolating the area and
setting the stage for tissue repair and regeneration (132). Furthermore,
a variety of MSC niches are reported locally within the dental pulp (eg,
perivascularly), and clearly MSC mobilization and homing are highly
dependent on the vascular and angiogenic responses. Further high-
lighting the importance of the angiogenic response in dental tissue de-
fense and repair are the data demonstrating the ability of dental MSCs to
robustly differentiate down endothelial cell lineages (45, 46, 133).
Once recruited, dental MSCs not only have repair characteristics, but
they are also immunomodulatory. Their properties include their
ability to suppress proinflammatory cytokine levels while
upregulating anti-inflammatory molecules, along with their ability to
directly temper immune cell behavior (134, 135). It is also of
significance that several chemokines and homing molecules are
shared by immune cells and MSCs, indicating the importance of the
crosstalk between these 2 arms of the tissue defense and repair
responses (77, 136) (Fig. 4).
Data from a variety of fields, in particular in mineralized tissue
wound healing, are now highlighting the interdependency between
inflammation, angiogenesis, and regeneration. It appears that although
low-grade or the early inflammatory response can promote tissue
repair, as might be seen beneath calcium hydroxide–based or mineral
trioxide restorations within the pulp (137–139), relatively high-grade
chronic inflammation negatively impacts directly on MSC function
and dentinogenic repair and can also delay angiogenesis (83, 140).
Translationally, the progressive influence of pulpal inflammation
on healing creates significant diagnostic responsibility when planningFigure 4. Schematic of potential steps and interactions between dental tissue inf
response occurs generally after carious bacterial infection, leading to mediator relea
factors, and other signaling molecules acts on MSCs, immune cells, and the vascular s
immune cell response is able to contain or remove the infection, potentially with the
JOE — Volume 42, Number 1, January 2016regenerative procedures to select cases that are likely to respond to
treatment. At present, pulpal inflammation is simply classified as revers-
ible, symptomatic, or asymptomatic irreversible pulpitis (141), with the
diagnosis established after pain history, clinical/radiographic examina-
tion, and pulpal sensibility tests. Traditionally it was believed that the re-
sults did not accurately reflect the true histopathologic status of the pulp
(142–144) and that new molecular diagnostic test would be required
for accurate diagnosis (145). Recently this has been questioned, and a
strong correlation has been shown between symptomatology, clinical
findings, and the histologic classification of pulp disease (146). How-
ever, to improve clinical outcome a better understanding of the interplay
between the reparative processes at the molecular level and clinical
signs and symptoms may enable the development of new therapeutic
modalities for regenerative endodontics.Exploiting Bioactive Molecules in Dentin-Pulp
Therapeutic application of a variety of bioactive molecules,
whether of natural or synthetic origin, to the injured pulp to promote
repair and regeneration has been proposed (147). Although such a
strategy is attractive in that it parallels the well-established techniques
used in pulp capping, a number of delivery and technical considerations
must be addressed. These particularly focus on the preservation of bio-
logical activity in a group of labile molecules, which presents significant
challenges for routine clinical use where their storage and delivery may
be challenging. An alternative strategy is to exploit the bioactive mole-
cules naturally sequestered within dentin. Those within dentin are pro-
tected while the tissue is in its mineralized state, and their local release at
sites of injury avoidsmany of the problems of effective clinical delivery in
the surgery. Some release of these molecules may occur as a conse-
quence of carious demineralization of the tissue and has the potential
to participate in natural regenerative events. However, more targetedection, inflammation, vascular responses, and regeneration. An inflammatory
se from host cells and demineralized dentin. This cocktail of cytokines, growth
ystem. There is significant crosstalk between these systems, and ultimately if the
involvement of clinical intervention, then dental tissue regeneration can occur.
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release might be achieved through local application of demineralizing
agents, a number of which are commonly used for tissue preparation
during endodontic procedures. Several studies have now highlighted
the potential of various agents, epigenetic modifiers, medicaments,
and materials to release and expose bioactive molecules in dentin to in-
fluence stem cell behavior (24, 49, 148–153). It is noteworthy that
initial revascularization-like procedures were designed with the goal
of maximum disinfection without taking into account the effect of the
chemical debridement on the availability of bioactive molecules present
in dentin and the survival and differentiation of stem cells. There is
increasing evidence that disinfection can be achieved while promoting
a microenvironment that is more suitable for regeneration. Thus, the
strategy of targeting endogenous bioactive molecules sequestered in
dentin can be achieved with minimal change to current endodontic
practice while retaining the fundamental need for adequate disinfection,
a pre-requirement for regeneration/repair.
Concluding Remarks
The future for regenerative endodontics offers exciting promise. In
the long-term it is envisaged that regrowth of entire tooth structures
within patients may be achievable; however, more short-term goals
along that clinical and research journey are now becoming more real-
istic. Indeed, our increasing understanding of the molecules involved
and cell behavior necessary for dentin-pulp complex repair will provide
new therapeutic avenues for exploitation. These approaches may well
be underpinned by the generation of biomimetic environments that
harness the tooth’s own natural ability to repair itself built on the basis
of our understating of its innate biological properties. Subsequently, it is
essential for continued and genuine clinical and basic science research
partnerships to enable challenging questions to be asked and answered
as well as to enable the translation of key research findings. These
studies will be inherently interdisciplinary at the interface between
both biological and physical sciences and in particular relating to bio-
materials, cell scaffolds, molecular biology, and stem cell biology.
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It was hypothesised that HDACis could solubilise a range of DMCs from powdered dentine 
and owing to their acidic nature, would remove or alter the smear layer remaining after 
dentine preparation. The aim of this study was to compare the solubilisation of a range of 
DMCs by three HDACis with characterised extractants, prior to compositional analyses of the 
extracts using high-throughput antibody arrays and protein assays. The authors proposed 
that the experimentation would provide evidence that HDACis could extract potentially 
bioactive DMCs, which may work in synchrony with DPC-generated bioactive molecules to 
promote dentine-pulp repair processes. If successful, the process would highlight a further 
mechanism by which an HDACi containing dental restorative materials could promote 
regenerative events if placed clinically within vital pulp treatment. 
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CHAPTER 9 
 
GENERAL DISCUSSION 
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9.1 Principal findings and discussion 
Untreated dental pulp inflammation, as a result of microbial infection, leads to necrosis, 
apical periodontitis and apical abscess formation (Cooper et al., 2011). Consequently, there 
is a need to develop biologically-based treatment protocols that harness the regenerative 
capacity of the pulp and maintain pulp vitality or replace irreversibly damaged or necrotic 
pulp tissue (Ferracane et al., 2010; Smith et al., 2016). Although the potential regenerative 
benefits of epigenetic-based therapeutic intervention have recently been highlighted in 
periodontology (Barros & Offenbacher, 2014), within endodontology there have been no 
previous investigations. Therefore, the main focus of the current research project was to 
investigate a novel role for the epigenetic-modifying agents, HDACis, in augmenting 
regenerative processes within vital pulp treatment.  
Within this research project, the hypothesis that HDACis could positively affect cell 
proliferation and differentiation to accelerate mineralisation events in dental pulp-derived 
cells was supported. Two broad spectrum HDACis (TSA and VPA) added to a dental-papillae 
derived cell line (MDPC-23), reduced proliferation and increased mineralisation dose-
dependently, which had not previously been reported. In addition, the application of HDACi, 
in relatively low concentrations (12.5-400 nM TSA; 0.125-5 mM VPA), adversely influenced 
cell viability and cell cycle only at the highest concentrations employed (400 nM TSA; 5 mM 
VPA) (Chapter 4; Duncan et al., 2012). Although this work demonstrated the principle of 
HDACi-induced pulp cell mineralisation, it also generated further questions regarding the 
potential nature of the response in primary/non-transformed cell cultures, which have been 
demonstrated to react differently to HDACi in other cellular systems (Ungerstedt et al., 
2005; Lee et al., 2010). Subsequent primary DPC experimentation supported the hypothesis, 
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that HDACi-induced reparative-related cellular responses at concentrations, which did not 
stimulate significant cytotoxic effects. Comparison between the two studies, however, 
revealed marked differences between the primary DPC and immortalised cell-line responses. 
Notably, the same HDACis (TSA and VPA) induced mineralisation at concentrations 10-fold 
lower in primary DPCs compared with the pulp cell-line. In terms of HDACi dosage, an 
increase in mineralisation per cell was evident after 24 h application of HDACi in the primary 
DPC group, but not after constant HDACi dosage up to 14 days, which conversely resulted in 
an inhibition of cell differentiation. This effect was not evident in the MDPC-23 cell cultures 
in which constant exposure to HDACi increased mineralisation. Primary DPC experimentation 
revealed no loss of cell viability or increase in apoptosis at the highest concentrations 
applied (400 nM TSA; 5 mM VPA), indicative a resistance of DPCs to HDACi-mediated toxicity 
not evident in MDPC-23 cells (Chapter 5; Duncan et al., 2013). From a translational 
perspective, the stimulation of mineralisation in DPCs without evidence of cell toxicity after 
a 24 h exposure to HDACi, supports the potential chairside application of HDACis as pulp 
capping agents within clinical vital pulp treatment protocols. 
The conclusion that 24 h HDACi application would induce reparative responses in 
primary DPCs required further investigation. As a result, the molecular mechanisms driving 
the regenerative properties of a clinically-approved HDACi, SAHA (Grant et al., 2007) were 
investigated. The studies focused on the expression of novel transcripts and the 
upregulation of mineralisation-associated pathways at the 24 h and 14 day time-points.  The 
hypothesis that the mechanism behind the regenerative properties of SAHA, related to the 
transcriptomic changes which modulate selected mineralisation-associated pathways and 
that certain novel markers interact with SAHA to promote and augment pulpal regenerative 
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processes was supported. The expression of several unreported and previously characterised 
genes, associated with mineralisation processes, were upregulated at both 24 h and 14 days. 
After gene expression pathway analysis, the significant upregulation of several members of 
the MMP family of endopeptidases (MMP-9, MMP-13 and MMP-17) and endochondral 
ossification pathway were highlighted as a potential mechanism for SAHA-stimulated 
mineralisation in DPCs (Duncan et al., 2015). Although the interaction between HDACi and 
MMPs was highlighted previously for transformed (Lin et al., 2012) and primary cell 
populations (Mayo et al., 2003; Schroeder et al., 2007), there had been no previous attempts 
to link this interaction to reparative processes in the dental pulp or elsewhere. Furthermore, 
experimentation which specifically investigated the interaction of HDACi and MMP-13 
demonstrated that SAHA promoted DPC mineralisation and induced MMP-13 expression and 
activity at both 24 h and 14 days. Interestingly, an increase in MMP-13 also mediated a 
SAHA-induced increase in DPC migration (Chapter 6; Duncan et al., 2016a). 
The hypothesis that HDACis would remove or alter the smear layer remaining after 
dentine preparation was not supported as all three HDACis studied (TSA, VPA and SAHA) did 
not remove or alter the smear layer. However, the hypothesis that HDACis would solubilise a 
range of DMCs was supported as TSA, VPA and SAHA were able to solubilise a range of DMCs 
which may promote bioactive repair responses clinically. Dentine is known to be a rich 
source of bioactive molecules and the HDACi-DMC extracts contained a range of GFs 
previously identified as being released from dentine by endodontic irrigants (Finkelman et 
al., 1990; Roberts-Clark & Smith, 2000) and the dental materials Ca(OH)2 and MTA (Graham 
et al., 2006; Tomson et al., 2007), as well as other uncharacterised GFs such as GDNF and 
BDNF (Chapter 8; Duncan et al., 2016b). Importantly, the HDACis extracted a range of GFs 
 50 
from dentine less efficiently than the well-characterised extractant EDTA (TGF-β-1, PDGF-AA 
and VEGF-A), but more effectively for others (GDF-15, IGF-1, EGRF-1, NGFR, SCF-R), while 
notably each HDACi exhibited a different extraction profile. The observations that HDACi 
solubilised DMCs have clinical relevance as both pulp capping agents and pulp engineering 
scaffolds contact dentine at the periphery of the pulp exposure or in the root canal system 
(Fig. 9.1), thereafter releasing bioactive DMCs, which promote reparative events (Graham et 
al., 2006). The project established a novel potential additional mechanism for HDACi action 
on reparative and regenerative dentine-pulp events in addition to direct cellular epigenetic 
actions, which have not previously been reported in the dental literature. 
 
9.2 Future work 
The present work offers detailed in vitro analyses of HDACi-induced DPC repair processes, 
highlighting novel transcripts and molecular pathways stimulated by HDACi, as well as 
characterising the release of DMCs by these inhibitors. A previously unreported role for 
epigenetic modification in the pulpal wound healing response was demonstrated, which 
provides a potential opportunity for therapeutic HDACi intervention during regenerative 
endodontic procedures (Fig. 9.1). In order to progress the translational potential of the 
study, the suggestion that the clinical topical application of HDACi promotes reparative 
processes during vital pulp or pulp engineering procedures (Duncan et al., 2016c) requires 
further investigation. An in vivo assessment, using animal models, of the healthy and 
inflamed pulpal responses to HDAC and MMP-13 inhibitors would be necessary to determine 
the clinical potential of the current in vitro studies. This work also provides a basis for further  
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.1 Schematic diagram highlighting the therapeutic potential of HDACis in regenerative endodontics. A. Vital pulp treatment. i. Deep carious lesion exposes pulp 
tissue. ii. A single dose of HDACi topically applied to exposed pulp, potentially as a component of a dental restorative material [mineral trioxide aggregate (MTA), calcium 
hydroxide, resin-based composite (RBC)] promotes tissue-repair processes, including increased mineralisation, modulated inflammation, organisation of mineralisation 
processes and cell migration. iii. Tooth suitably restored over capping material with amalgam, RBC or glass ionomer and mineralised bridge formation evident under dental 
pulp capping material. B. Pulp tissue engineering. i. Pulp necrosis caused by trauma, caries or microleakage around restoration. ii. Necrotic tooth chemo-mechanical 
debrided and EDTA, NaOCl applied to dentine to release matrix components (Conde et al., 2015). iii. HDACi applied within a cell or non-cell based scaffold stimulates 
further growth factor release, migration of cells and differentiation processes. iv. Tooth restored and new pulp-like tissue formed promoting continued root growth and 
restoring tooth tissue vitality.                                                                                                   
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investigations into several related areas of research which are described below, in the 
immediate-, medium- and long-term, which should increase our understanding of the 
influence of epigenetics and specifically HDACi on dentine-pulp repair and regeneration. 
The experimental work presented has currently focussed on the actions of three 
HDACis (TSA, VPA and SAHA), which offer pan-specific inhibition for zinc-dependent HDACs 
being effective against all Class I (HDAC-1, -2, -3, -8), Class II (HDAC-4, -5, -6, -9, -10) and 
Class IV (HDAC-11) enzymes (Marks & Dokmanovic, 2005), but not the Class III HDACs known 
as sirtuins (Haigis & Guarente, 2006). As there are multiple, opposing cellular effects of 
HDAC (Balasubramanian et al., 2009) and the expression of class II HDAC enzymes is tissue 
dependent (Verdin et al., 2003), the development of isoform specific HDACi has been 
advocated (Khan et al., 2008; Muraglia et al., 2008).  Therefore, in the immediate-term I 
would aim to focus the research in two specific areas; (i) expression analyses of individual 
class II HDAC enzymes in pulp tissue and changes in expression during disease and repair, 
with a view to investigating isoform-specific HDACi; and (ii) the effects of HDACi and MMP-
13i in vital pulp treatment in vivo, initially in an animal model and later using HDAC-specific 
knock-out mice (Lee & Partridge, 2010; Kim et al., 2012).  
Depending on the results of the next phase of experimentation, medium-term 
research plans could include an investigation of a potential anti-inflammatory HDACi role in 
pulp cell cultures and in vivo models of pulpal inflammation (Renard et al., 2016) with 
optimisation of the dental restorative material aspects for the delivery of HDACi to the 
pulpal wound site (Paranjpe et al., 2008). Long-term research goals would be to engage in a 
prospective controlled clinical trial investigating the histological and clinical efficacy of HDACi 
as an adjunct to vital pulp treatment protocols (Nair et al., 2008) or as a scaffold morphogen 
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to functionally assist pulp tissue engineering procedures (Rosa et al., 2013; Albuquerque et 
al., 2014; Piva et al., 2014; Conde et al., 2015) (Fig. 9.1). Further epigenetic-modifier based 
projects can be developed alongside the proposed studies since although the current project 
has concentrated on the effects of one group of epigenetic-modifying agents, other agents 
targeting DNA and histone methylation also provide therapeutic candidates for treatment of 
damaged pulp tissue (Zhang et al., 2015). The use of DNA methyl transferase inhibitors alone 
or in combination with HDACis presents a potentially exciting area of future research 
(Mahpatra et al., 2010).  
 
9.3 Conclusions 
Concerns over the destructive nature of dental treatment protocols have led the dental 
profession to examine methodologies that develop regenerative treatment protocols and 
promote minimally-invasive, biologically-based dental restorative solutions (Banerjee, 2013; 
Schmalz & Smith, 2014). Within endodontics, this has resulted in a shift towards 
regenerative endodontic procedures aimed to protect the pulp and harness its natural 
regenerative capacity or facilitate the engineering of new pulp tissue (Cordeiro et al., 2008) 
when irreversibly inflamed or necrotic. Traditionally, vital pulp treatments have 
unpredictable clinical outcomes, in part due to poor inflammatory control or low quality 
mineralised tissue formation at the exposure site (Cox et al., 1996; Nair et al., 2008). The 
research presented highlights an exciting opportunity for the topical use of the epigenetic-
modifying-agents, HDACis, in augmenting tissue repair processes during regenerative 
endodontic procedures. Data presented have demonstrated the previously unreported 
influence of epigenetics and in particular HDAC function on the molecular signalling 
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controlling cell fate, cell behaviour and cell differentiation, although, the complexity of 
epigenetic modifications was also highlighted. The paucity of published laboratory data 
necessitates future research prior to, and alongside, any proposed changes to clinical 
treatment protocols. The observation that HDACi promoted both DPC mineralisation and 
migration modulated by changes in MMP activity, highlighted other potential therapeutic 
targets or combinatorial therapies that could provide a focus for future research and clinical 
application in this area. Translationally, HDACi-induced DMC release presents further 
evidence for a potential benefit of augmenting a dental restorative material or tissue 
engineering scaffolds with HDACi as a basis for new biologically-based endodontic treatment 
protocols in the future. 
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EndodonticsDental pulp tissue can be damaged by a range of irritants, however, if the irritation is removed and/or the tooth is
adequately restored, pulp regeneration is possible (Mjör and Tronstad, 1974 [1]). At present, dental restorative
materials limit healing by impairing mineralization and repair processes and as a result new biologically-based
materials are being developed (Ferracane et al., 2010 [2]). Previous studies have highlighted the beneﬁt of epige-
netic modiﬁcation by histone deacetylase inhibitor (HDACi) application to dental pulp cells (DPCs), which
induces changes to chromatin architecture, promoting gene expression and cellular-reparative events (Duncan
et al., 2013 [3]; Paino et al., 2014 [4]). In this study a genome-wide transcription proﬁling in epigenetically-
modiﬁed mineralizing primary DPC cultures was performed, at relatively early and late time-points, to identify
differentially regulated transcripts that may provide novel therapeutic targets for use in restorative dentistry.
Here we provide detailed methods and analysis on these microarray data which has been deposited in Gene
Expression Omnibus (GEO): GSE67175.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
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2. Experimental design, materials and methods
2.1. Primary cell culture
Primary DPCs were isolated from the extirpated pulp tissue of
freshly extracted rodent incisor teeth using enzymatic disaggregation
procedure as previously described [5]. The maxillary and mandibular
incisor teeth were dissected from male Wistar Hannover rats aged 25–
30 days and weighing 120–140 g. The pulp tissue was extirpated from
the pulp chamber, minced with a scalpel into 1 mm3 pieces and trans-
ferred into Hank's balanced salt solution (Sigma-Aldrich, Arklow,
Ireland) prior to incubation at 37 °C, 5% CO2 for 30 min (MCO-18AC
incubator, Sanyo Electric, Osaka, Japan). Cells were transferred to an
equal volume of supplemented α-MEM (Biosera, East Sussex, UK)
containing 1% (w/v) penicillin/streptomycin (Sigma-Aldrich) and 10%
(v/v) fetal calf serum (FCS) (Biosera). A single cell suspension wasthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. A comparison of N2 fold gene expression at 24 h and 14 days in DPCs after exposure
to SAHA for 24 h. The ‘heat-map’ shows expression patterns for all present genes.
392 H.F. Duncan et al. / Genomics Data 5 (2015) 391–393obtained by passing through a 70 μm cell sieve (BD Biosciences, Oxford,
UK) prior to centrifugation and re-suspension in 1 ml supplemented α-
MEM. DPCs were expanded under standard culture conditions to
passage 2. The DPCs were seeded in supplemented α-MEM for 3
days (experimental day 0), and then either cultured for 24 h in supple-
mented mineralizing medium containing 1 μM SAHA prior to harvest
(24 h samples) or incubated with an HDACi-free mineralizing medium
for a further 13 days (14 day samples). Control samples contained
cells cultured in mineralizing medium without SAHA.
2.2. Suberoylanilide hydroxamic acid (SAHA) preparation
A5mMstock solutionof SAHA(N-hydroxy-N′-phenyl-octanediamide)
(Sigma-Aldrich), in dimethyl sulfoxide (DMSO) was diluted in phos-
phate buffered saline (PBS) (Sigma-Aldrich) prior to further dilution
to 1 μM with supplemented α-MEM.
2.3. RNA isolation, cDNA and labeled cRNA preparation
Cultures were detached (trypsin/EDTA), homogenized and RNA
extracted using the RNeasy mini kit (Qiagen, West Sussex, UK), before
being quantiﬁed spectrophotometrically (Nanodrop 2000, Thermo
Fisher Scientiﬁc). A 75 ng aliquot of total RNA was converted to cDNA
using an oligo dT-promoter primer and Afﬁnity-Script-RT (Agilent
Technologies), prior to being labeled with either Cyanine 3-CTP or
Cyanine 5-CTP using the Two-Color Low Input Quick Amp labeling
Kit (Agilent Technologies, Cork, Ireland) and transcribed to cRNA
(Agilent Technologies). The cRNA was puriﬁed using the RNeasy
mini kit (Qiagen) and Cy3, Cy5 concentration, RNA absorbance 260/
280 nm and cRNA concentrations determined spectrophotometrically
(Nanodrop 2000, Wilmington, DE, USA). This enabled speciﬁc activity
and target yields to be calculated prior to microarray experimentation.
2.4. Microarray experimentation and analysis
The Agilent 4x44K v3 whole rat genome oligonucleotide gene
expression microarray (Agilent Technologies) was used to analyze the
transcript proﬁles of HDACi treated (1 μM SAHA) and untreated DPC
cultures at both 24 h and 14 days under mineralizing conditions. The
microarray analyses were performed on quadruplicate independent
DPC cultures (n = 4) at both time-points. A total of 825 ng of labeled
cRNA from each sample (treated and untreated)was loaded onto an in-
dividual array according to the manufacturer's instructions and co-
hybridized at 65 °C for 17 h, washed and scanned in GenePix-Person-
al 4100A, Pro 6.1 (Axon, Molecular Devices, CA, USA) at a resolution
of 5 μm.
Raw data were exported to GeneSpring GX12 and signals for each
replicate spot were background corrected and normalized using Lowess
transformation. Log2 ﬂuorescent intensity ratios were generated for
each replicate spot and averaged. Genes that were differentially
expressed (N2.0 fold) in the SAHA group relative to control were iden-
tiﬁed after passing a t-test (p b 0.05), post-hoc test (Storey with
bootstrapping) with a corrected q value of 0.05 (Fig. 1). Genes in the
expression datasets were ﬁrst ‘ranked’ based on Log2 values from the
highest to lowest for both groups at both time points, prior to hierarchi-
cal clustering being used to group gene expression in each condition
using the default settings in Genespring GX12. Gene Ontology (GO)
was evaluated using Go-Elite (http://www.genmapp.org/go_elite) [6],
which is designed to identify a minimal non-redundant set of biological
Ontology terms to describe a particular set of genes (Fig. 2).
2.5. Validation of microarray data by quantitative RT-PCR analysis
In order to validate the microarray, isolated RNA was converted to
single-stranded cDNA using the TaqMan™ reverse transcriptase kit
and 50 μM random hexamers (Life Technologies) and theconcentrations determined spectrophotometrically (Nanodrop 2000,
Thermo Fisher Scientiﬁc). A range of transcripts was selected based on
their levels of differential regulation. The q-RT-PCR analysis was per-
formed for rat genes using speciﬁc primers (Invitrogen, Life Technolo-
gies, Thermo Scientiﬁc, Paisley, UK) for Dab1, Gsta4, Hist1h1b, Ska1,
Epha3, Krt18, Mal2 and Rasgrp13. Primers for each selected gene were
designed using Primer3Plus tools (http://primer3plus.com/). Sequence
identity of the amplicon was conﬁrmed with NCBI Basic Local Align-
ment Search Tool (blast) software (http://blast.ncbi.nlm.nih.gov/Blast.
cgi)Synthesized cDNA was ampliﬁed and PCRs performed using the
Applied Biosystems 7500 Fast Real-Time PCR thermal cycler (Applied
Biosystems), being subjected to a designated number of ampliﬁcation
cycles (40 cycles), where a typical cycle was 95 °C for 3 s and 60 °C for
30 s. Real-time PCR data were normalized to β-actin. The upregulated
and downregulated transcripts assayed by RT = PCR were consistent
with the results obtained from DNA microarray (Table 1).3. Discussion
In this report we describe detailed technical methods to reproduce
the high-throughput gene analysis using the whole rat genome oligo
microarray kit (Agilent, G2519F, Ireland) for mineralizing primary DPC
Table 1
A comparison of microarray and quantitative RT-PCR for selected genes at 24 h and 14
days.
Gene Fold change cDNA microarray (24 h) Fold change RT-PCR (24 h)
Dab1 4.13 5.17
Gsta4 8.21 14.5
Hist1h1b −7.83 −13.0
Ska1 −97.2 −72.5
Gene Fold change cDNA microarray (14
days)
Fold change RT-PCR (14
days)
Epha3 −2.4 −2.06
Krt18 −2.8 −2.65
Mal2 2.83 2.73
Rasgrp13 2.33 2.32
Fig. 2. Functional categories of the genes showing signiﬁcant N2 fold expression change in DPCs at 24 h relative to control. A, Biological categories of the transcripts were assigned with
GoElite (http://www.genmapp.org/go_elite) analysis software and further subdivided by category; B, Cellular component; C, molecular function; and D, biological process. Only GoTerms
categories with greater than 7 transcript members are included.
393H.F. Duncan et al. / Genomics Data 5 (2015) 391–393cultures in the presence and absence of a HDACi. The validated gene
expression data demonstrates the relevant expression proﬁle signature
of differentially expressed genes during mineralization and identiﬁes
several transcripts not previously associated with this process. This
data can contribute to future investigations examining transcriptional
changes that promote tissue repair processes in the dental pulp.Acknowledgments
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